TANY0051 personal page - To The Moon

TANY0051

TANY0051

No personal profile

11Follow

2Followers

1Topic

0Badge

2022-01-03

Continue to create more good news in 2022.

Sorry, the original content has been removed

2021-08-06

Great

Nasdaq, S&P 500, set records as jobless claims decline

2022-01-08

Great 👍

Tesla Semis Could Be Delivered To PepsiCo In Late January

2021-09-01

Go go go

Moderna shares rose more than 2% in early trading

2021-08-25

Way to go

Moderna shares surged 4% in morning trading

2024-02-16

$SINGAPORE AIRLINES LTD(C6L.SI)$ Continue to grow

2021-08-13

[Smile]

BioNTech, Moderna Rise On Nod To Booster For Those With Weak Immunity

2021-08-09

[Sad]

Alibaba shares fell 1.57% in premarket trading.

2021-09-02

Way to go

Sorry, the original content has been removed

2021-08-26

$Inovio Pharmaceuticals(INO)$Go go go

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"4087614954520500","uuid":"4087614954520500","gmtCreate":1625249193179,"gmtModify":1626320608339,"name":"TANY0051","pinyin":"tany0051","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/45437e79e37475d2911f2a4b2f84983d","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":11,"tweetSize":0,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":1,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.08.12","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":5,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":274441423143176,"gmtCreate":1708040095129,"gmtModify":1708040097687,"author":{"id":"4087614954520500","authorId":"4087614954520500","name":"TANY0051","avatar":"https://static.tigerbbs.com/45437e79e37475d2911f2a4b2f84983d","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087614954520500","idStr":"4087614954520500"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$&nbsp;</a> Continue to grow","listText":"<a href=\"https://ttm.financial/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$&nbsp;</a> Continue to grow","text":"$SINGAPORE AIRLINES LTD(C6L.SI)$ Continue to grow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/274441423143176","isVote":1,"tweetType":1,"viewCount":2423,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":252032357503216,"gmtCreate":1702550455829,"gmtModify":1702550459993,"author":{"id":"4087614954520500","authorId":"4087614954520500","name":"TANY0051","avatar":"https://static.tigerbbs.com/45437e79e37475d2911f2a4b2f84983d","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087614954520500","idStr":"4087614954520500"},"themes":[],"htmlText":"Hold","listText":"Hold","text":"Hold","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/252032357503216","repostId":"2391628565","repostType":4,"repost":{"id":"2391628565","kind":"highlight","pubTimestamp":1702542909,"share":"https://ttm.financial/m/news/2391628565?lang=en_US&edition=fundamental","pubTime":"2023-12-14 16:35","market":"us","language":"en","title":"Tesla Stock: Buy, Sell, or Hold for 2024 and Beyond?","url":"https://stock-news.laohu8.com/highlight/detail?id=2391628565","media":"Motley Fool","summary":"The hot stock nearly doubled this year. What's next?","content":"<div>\n<p>KEY POINTSTesla benefits from an array of big catalysts.The electric-car maker's self-driving software could morph into a major tailwind for the automaker.Looking to 2024, Tesla faces several ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/12/13/tesla-stock-buy-sell-or-hold-for-2024-and-beyond/\">Source Link</a>\n\n</div>\n","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla Stock: Buy, Sell, or Hold for 2024 and Beyond?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla Stock: Buy, Sell, or Hold for 2024 and Beyond?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-12-14 16:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/12/13/tesla-stock-buy-sell-or-hold-for-2024-and-beyond/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSTesla benefits from an array of big catalysts.The electric-car maker's self-driving software could morph into a major tailwind for the automaker.Looking to 2024, Tesla faces several ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/12/13/tesla-stock-buy-sell-or-hold-for-2024-and-beyond/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4551":"寇图资本持仓","LU0719512351.SGD":"JPMorgan Funds - US Technology A (acc) SGD","BK4099":"汽车制造商","LU1861559042.SGD":"日兴方舟颠覆性创新基金B SGD","LU0316494557.USD":"FRANKLIN GLOBAL FUNDAMENTAL STRATEGIES \"A\" ACC","LU0348723411.USD":"ALLIANZ GLOBAL HI-TECH GROWTH \"A\" (USD) INC","BK4548":"巴美列捷福持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","LU1720051017.SGD":"Allianz Global Artificial Intelligence AT Acc H2-SGD","LU0823414478.USD":"法巴经典能源转换基金","IE00B1XK9C88.USD":"PINEBRIDGE US LARGE CAP RESEARCH ENHANCED \"A\" (USD) ACC","BK4511":"特斯拉概念","LU1839511570.USD":"WELLS FARGO GLOBAL FACTOR ENHANCED EQUITY \"I\" (USD) ACC","LU2063271972.USD":"富兰克林创新领域基金","LU1429558221.USD":"Natixis Loomis Sayles US Growth Equity RA USD","LU1551013425.SGD":"Allianz Income and Growth Cl AMg2 DIS H2-SGD","LU0053666078.USD":"摩根大通基金-美国股票A（离岸）美元","TSLL":"2倍做多TSLA ETF-Direxion","LU1861215975.USD":"贝莱德新一代科技基金 A2","LU1435385759.SGD":"Natixis Loomis Sayles US Growth Equity RA SGD-H","LU0823411888.USD":"法巴消费创新基金 Cap","TSLA":"特斯拉","LU2357305700.SGD":"Allianz Global Artificial Intelligence ET H2-SGD","LU1861220033.SGD":"Blackrock Next Generation Technology A2 SGD-H","LU1548497426.USD":"安联环球人工智能AT Acc","BK4585":"ETF&股票定投概念","BK4534":"瑞士信贷持仓","LU1914381329.SGD":"Allianz Best Styles Global Equity Cl ET Acc H2-SGD","LU0082616367.USD":"摩根大通美国科技A（dist）","LU0056508442.USD":"贝莱德世界科技基金A2","LU0097036916.USD":"贝莱德美国增长A2 USD","LU0466842654.USD":"HSBC ISLAMIC GLOBAL EQUITY INDEX \"A\" (USD) ACC","BK4555":"新能源车","LU0820561909.HKD":"ALLIANZ INCOME AND GROWTH \"AM\" (HKD) INC","LU2087621335.USD":"ALLSPRING GLOBAL FACTOR ENHANCED EQUITY \"A\" (USD) ACC","LU1861558580.USD":"日兴方舟颠覆性创新基金B","LU0689472784.USD":"安联收益及增长基金Cl AM AT Acc","LU1852331112.SGD":"Blackrock World Technology Fund A2 SGD-H","BK4178":"家庭装饰零售","LU2326559502.SGD":"Natixis Loomis Sayles US Growth Equity P/A SGD-H","BK4592":"伊斯兰概念","LU0198837287.USD":"UBS (LUX) EQUITY SICAV - USA GROWTH \"P\" (USD) ACC","LU0820562030.AUD":"ALLIANZ INCOME AND GROWTH \"AMH2\" (AUDHDG) H2 INC","BK4550":"红杉资本持仓","LU0820561818.USD":"安联收益及增长平衡基金Cl AM DIS","BK4581":"高盛持仓","LU2602419157.SGD":"HSBC ISLAMIC GLOBAL EQUITY INDEX \"AC\" (SGD) ACC","BK4527":"明星科技股","LU1720051108.HKD":"ALLIANZ GLOBAL ARTIFICIAL INTELLIGENCE \"AT\" (HKD) ACC"},"source_url":"https://www.fool.com/investing/2023/12/13/tesla-stock-buy-sell-or-hold-for-2024-and-beyond/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2391628565","content_text":"KEY POINTSTesla benefits from an array of big catalysts.The electric-car maker's self-driving software could morph into a major tailwind for the automaker.Looking to 2024, Tesla faces several undeniable challenges.Tesla stock has served investors well in 2023. The electric-car maker's shares have soared more than 90% year to date. Indeed, the growth stock's performance has been so staggering that investors are now regularly referencing the stock's membership in the elite club called the \"Magnificent Seven.\" The group features seven large technology companies that collectively trounced the S&P 500's returns this year.With such strong performance from Tesla in 2023, the growth stock once again became a Wall Street darling. Are more big returns ahead for the stock in 2024 and beyond? Or has the stock become overvalued? Let's explore whether the stock looks more like a buy, hold, or sell today.Big growth driversThere's no denying the array of strong growth drivers Tesla has supporting its business.First, there's the secular momentum it's seeing from increasing demand for electric cars. This has played a big role in the company's 42% year-over-year growth in trailing-12-month deliveries.Of course, Tesla is also seeing incredible momentum in its energy storage business as utilities are turning to the company's utility-scale battery pack systems to stabilize the grid, prevent outages, and reduce costs. Its energy storage deployments, measured in gigawatt hours, soared 90% year over year in Q3.Additionally, the automaker delivered the first units of its new all-electric Cybertruck in late November. While deliveries of the vehicle likely won't ramp up to any meaningful volume until sometime around the end of 2024, the vehicle importantly gives Tesla access to the massive and lucrative pickup truck market.Finally, investors shouldn't underestimate the potential of Tesla's full self-driving software. While the software is still in beta, it already has formidable pricing power with consumers. Even in beta, the software upgrade costs Tesla owners a whopping $12,000. Despite the high price tag, tons of customers are opting in. Impressively, Tesla's vehicle fleet has already cumulatively driven more than 0.5 billion miles using full self-driving software, giving Tesla a massive set of data and analytics to rapidly improve the artificial intelligence (AI) supporting the software.It would be difficult to overstate the importance of Tesla's self-driving efforts to management. \"We will continue to invest significantly in AI development as this is really the massive game changer,\" said Tesla CEO Elon Musk during the company's third-quarter earnings call when discussing its full self-driving technology development. \"... success in this regard, in the long term, I think, has the potential to make Tesla the most valuable company in the world by far,\" Musk said.  Undeniable headwindsWith all of this said, three undeniable headwinds for the stock make it a hold at its current price rather than a buy.Tesla stock's high valuation of more than 75 times earnings arguably already prices in significant success, leaving very little room for error.High interest rates have made vehicle affordability more difficult and Tesla has had to respond by lowering prices (there's no telling how long interest rates could remain elevated).There's always a risk that investors are underestimating how costly it will be for Tesla to execute on its growth plans.For these three reasons, Tesla stock should be viewed more like a hold at its current valuation than a buy despite its business momentum and its long runway for further growth. However, if shares took a 25% to 30% haircut, it might be time to accumulate shares of this disruptive innovator.","news_type":1,"symbols_score_info":{"TSLA":1,"TSLL":1}},"isVote":1,"tweetType":1,"viewCount":2474,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9995913336,"gmtCreate":1661392408327,"gmtModify":1676536510655,"author":{"id":"4087614954520500","authorId":"4087614954520500","name":"TANY0051","avatar":"https://static.tigerbbs.com/45437e79e37475d2911f2a4b2f84983d","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087614954520500","idStr":"4087614954520500"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/TSLA\">$Tesla Motors(TSLA)$</a><v-v data-views=\"1\"></v-v>","listText":"<a href=\"https://ttm.financial/S/TSLA\">$Tesla Motors(TSLA)$</a><v-v data-views=\"1\"></v-v>","text":"$Tesla Motors(TSLA)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9995913336","isVote":1,"tweetType":1,"viewCount":2768,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9027892630,"gmtCreate":1654004704820,"gmtModify":1676535376733,"author":{"id":"4087614954520500","authorId":"4087614954520500","name":"TANY0051","avatar":"https://static.tigerbbs.com/45437e79e37475d2911f2a4b2f84983d","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087614954520500","idStr":"4087614954520500"},"themes":[],"htmlText":"No doubts, he will be","listText":"No doubts, he will be","text":"No doubts, he will be","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9027892630","isVote":1,"tweetType":1,"viewCount":2453,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9006197088,"gmtCreate":1641629081547,"gmtModify":1676533636108,"author":{"id":"4087614954520500","authorId":"4087614954520500","name":"TANY0051","avatar":"https://static.tigerbbs.com/45437e79e37475d2911f2a4b2f84983d","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087614954520500","idStr":"4087614954520500"},"themes":[],"htmlText":"Great 👍&nbsp;","listText":"Great 👍&nbsp;","text":"Great 👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006197088","repostId":"1150907621","repostType":4,"repost":{"id":"1150907621","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1641607621,"share":"https://ttm.financial/m/news/1150907621?lang=en_US&edition=fundamental","pubTime":"2022-01-08 10:07","market":"us","language":"en","title":"Tesla Semis Could Be Delivered To PepsiCo In Late January","url":"https://stock-news.laohu8.com/highlight/detail?id=1150907621","media":"Benzinga","summary":"Electric vehicle giantTesla Incsurprised investors and customers in 2021 with an announcement that the highly anticipatedTesla Semiwould be delayed. A new report shows Semi deliveries could be just ar","content":"<html><head></head><body><p>Electric vehicle giant <b>Tesla Inc</b> surprised investors and customers in 2021 with an announcement that the highly anticipated <b>Tesla Semi</b> would be delayed. A new report shows Semi deliveries could be just around the corner.</p><p><img src=\"https://static.tigerbbs.com/9e0d630cfe6e37cabddb2883f1e52636\" tg-width=\"685\" tg-height=\"375\" width=\"100%\" height=\"auto\"/></p><p><b>What Happened:</b>A <b>Frito-Lay</b> facility in Modesto, California received Tesla Megachargers recently and is set to receive deliveries of Tesla Semis.</p><p>The <b>PepsiCo, Inc.</b> facility could receive Tesla Semis later this month, according to a report from Drive Tesla. Photos show Megachargers ready for installation and some in packaging. A Megapack battery storage system is also installed at the facility.</p><p><b>“After receiving these photos we were able to confirm with one of our sources that PepsiCo has been told to expect to receive all 15 Tesla Semis before the end of January,”</b>Drive Tesla said.</p><p>PepsiCo announced in a press release in March 2021 they would take delivery of 15 Tesla Semis before the end of 2021.</p><p>Tesla announced it was delaying the Tesla Semi during the second-quarter earnings release in 2021. Tesla CEO <b>Elon Musk</b> cited limited battery supply as one of the reasons for the Tesla Semi delay.</p><p>Despite the announced delays, PepsiCo CEO <b>Ramon Laguarta</b> shared in a CNBC interview in November 2021 that the company would be receiving Tesla Semis soon.</p><p>“We are getting our first deliveries this Q4,” Laguarta said.</p><p><b>Why It’s Important:</b>The comments from Laguarta suggested that Pepsi could have a different timeline than other companies or have preferred status from Tesla.</p><p>The purchase of Tesla Semis is one of several planned initiatives by PepsiCo to reduce its carbon emissions in the future, Laguarta added.</p><p>Pepsi is one of several large companies that have pledged to order Tesla Semis in the future. Pepsi placed an initial order for 100 Tesla Semis in 2017.</p><p>Tesla delayed the Tesla Semi into 2022 and new reports by the end of 2021 suggested Tesla Semis would not be delivered until 2023.</p><p><b>If reports hold true and PepsiCo receives its 15 Tesla Semis, it could lead to an improved timeline. But, it might be a one-off event possibly based on an exclusive deal or certain terms.</b></p><p>Tesla could see an increase in orders after its Tesla Semi is delivered. The event could also lead to public comments from PepsiCo that could lead to increased brand awareness of the semi-truck.</p><p>Investors and analysts eagerly await more updates on the Tesla Semi.</p><p><b>TSLA Price Action:</b>Tesla shares closed lower 3.54% at $1,026.96 on Friday.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla Semis Could Be Delivered To PepsiCo In Late January</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla Semis Could Be Delivered To PepsiCo In Late January\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2022-01-08 10:07</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Electric vehicle giant <b>Tesla Inc</b> surprised investors and customers in 2021 with an announcement that the highly anticipated <b>Tesla Semi</b> would be delayed. A new report shows Semi deliveries could be just around the corner.</p><p><img src=\"https://static.tigerbbs.com/9e0d630cfe6e37cabddb2883f1e52636\" tg-width=\"685\" tg-height=\"375\" width=\"100%\" height=\"auto\"/></p><p><b>What Happened:</b>A <b>Frito-Lay</b> facility in Modesto, California received Tesla Megachargers recently and is set to receive deliveries of Tesla Semis.</p><p>The <b>PepsiCo, Inc.</b> facility could receive Tesla Semis later this month, according to a report from Drive Tesla. Photos show Megachargers ready for installation and some in packaging. A Megapack battery storage system is also installed at the facility.</p><p><b>“After receiving these photos we were able to confirm with one of our sources that PepsiCo has been told to expect to receive all 15 Tesla Semis before the end of January,”</b>Drive Tesla said.</p><p>PepsiCo announced in a press release in March 2021 they would take delivery of 15 Tesla Semis before the end of 2021.</p><p>Tesla announced it was delaying the Tesla Semi during the second-quarter earnings release in 2021. Tesla CEO <b>Elon Musk</b> cited limited battery supply as one of the reasons for the Tesla Semi delay.</p><p>Despite the announced delays, PepsiCo CEO <b>Ramon Laguarta</b> shared in a CNBC interview in November 2021 that the company would be receiving Tesla Semis soon.</p><p>“We are getting our first deliveries this Q4,” Laguarta said.</p><p><b>Why It’s Important:</b>The comments from Laguarta suggested that Pepsi could have a different timeline than other companies or have preferred status from Tesla.</p><p>The purchase of Tesla Semis is one of several planned initiatives by PepsiCo to reduce its carbon emissions in the future, Laguarta added.</p><p>Pepsi is one of several large companies that have pledged to order Tesla Semis in the future. Pepsi placed an initial order for 100 Tesla Semis in 2017.</p><p>Tesla delayed the Tesla Semi into 2022 and new reports by the end of 2021 suggested Tesla Semis would not be delivered until 2023.</p><p><b>If reports hold true and PepsiCo receives its 15 Tesla Semis, it could lead to an improved timeline. But, it might be a one-off event possibly based on an exclusive deal or certain terms.</b></p><p>Tesla could see an increase in orders after its Tesla Semi is delivered. The event could also lead to public comments from PepsiCo that could lead to increased brand awareness of the semi-truck.</p><p>Investors and analysts eagerly await more updates on the Tesla Semi.</p><p><b>TSLA Price Action:</b>Tesla shares closed lower 3.54% at $1,026.96 on Friday.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1150907621","content_text":"Electric vehicle giant Tesla Inc surprised investors and customers in 2021 with an announcement that the highly anticipated Tesla Semi would be delayed. A new report shows Semi deliveries could be just around the corner.What Happened:A Frito-Lay facility in Modesto, California received Tesla Megachargers recently and is set to receive deliveries of Tesla Semis.The PepsiCo, Inc. facility could receive Tesla Semis later this month, according to a report from Drive Tesla. Photos show Megachargers ready for installation and some in packaging. A Megapack battery storage system is also installed at the facility.“After receiving these photos we were able to confirm with one of our sources that PepsiCo has been told to expect to receive all 15 Tesla Semis before the end of January,”Drive Tesla said.PepsiCo announced in a press release in March 2021 they would take delivery of 15 Tesla Semis before the end of 2021.Tesla announced it was delaying the Tesla Semi during the second-quarter earnings release in 2021. Tesla CEO Elon Musk cited limited battery supply as one of the reasons for the Tesla Semi delay.Despite the announced delays, PepsiCo CEO Ramon Laguarta shared in a CNBC interview in November 2021 that the company would be receiving Tesla Semis soon.“We are getting our first deliveries this Q4,” Laguarta said.Why It’s Important:The comments from Laguarta suggested that Pepsi could have a different timeline than other companies or have preferred status from Tesla.The purchase of Tesla Semis is one of several planned initiatives by PepsiCo to reduce its carbon emissions in the future, Laguarta added.Pepsi is one of several large companies that have pledged to order Tesla Semis in the future. Pepsi placed an initial order for 100 Tesla Semis in 2017.Tesla delayed the Tesla Semi into 2022 and new reports by the end of 2021 suggested Tesla Semis would not be delivered until 2023.If reports hold true and PepsiCo receives its 15 Tesla Semis, it could lead to an improved timeline. But, it might be a one-off event possibly based on an exclusive deal or certain terms.Tesla could see an increase in orders after its Tesla Semi is delivered. The event could also lead to public comments from PepsiCo that could lead to increased brand awareness of the semi-truck.Investors and analysts eagerly await more updates on the Tesla Semi.TSLA Price Action:Tesla shares closed lower 3.54% at $1,026.96 on Friday.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":4250,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001945811,"gmtCreate":1641166307069,"gmtModify":1676533576900,"author":{"id":"4087614954520500","authorId":"4087614954520500","name":"TANY0051","avatar":"https://static.tigerbbs.com/45437e79e37475d2911f2a4b2f84983d","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087614954520500","idStr":"4087614954520500"},"themes":[],"htmlText":"Continue to create&nbsp;more good news in 2022.&nbsp;","listText":"Continue to create&nbsp;more good news in 2022.&nbsp;","text":"Continue to create more good news in 2022.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001945811","repostId":"2200544080","repostType":4,"isVote":1,"tweetType":1,"viewCount":3976,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":815861006,"gmtCreate":1630666873305,"gmtModify":1676530370666,"author":{"id":"4087614954520500","authorId":"4087614954520500","name":"TANY0051","avatar":"https://static.tigerbbs.com/45437e79e37475d2911f2a4b2f84983d","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087614954520500","idStr":"4087614954520500"},"themes":[],"htmlText":"[Miser]&nbsp;","listText":"[Miser]&nbsp;","text":"[Miser]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/815861006","repostId":"1168724079","repostType":4,"isVote":1,"tweetType":1,"viewCount":3291,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":815923670,"gmtCreate":1630636890490,"gmtModify":1676530362807,"author":{"id":"4087614954520500","authorId":"4087614954520500","name":"TANY0051","avatar":"https://static.tigerbbs.com/45437e79e37475d2911f2a4b2f84983d","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087614954520500","idStr":"4087614954520500"},"themes":[],"htmlText":"[OMG]&nbsp;","listText":"[OMG]&nbsp;","text":"[OMG]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/815923670","repostId":"1103995208","repostType":4,"repost":{"id":"1103995208","kind":"news","pubTimestamp":1630629549,"share":"https://ttm.financial/m/news/1103995208?lang=en_US&edition=fundamental","pubTime":"2021-09-03 08:39","market":"us","language":"en","title":"Tesla Halted Production In China For 4 Days In August Due To The Semiconductor Shortage","url":"https://stock-news.laohu8.com/highlight/detail?id=1103995208","media":"zerohedge","summary":"Production output for Tesla in China has reportedly once again been halted and is being  blamed on the global semiconductor shortage.Short of the pandemic, the semi shortage has become a very convenient scapegoat, especially for the auto industry, for numerous manufacturers who have shut down production temporarily and idled plants throughout 2021.Tesla's Shanghai plant was halted \"for about four days\" in August, according to anew report from Reuters.In China, Tesla sold 32,968 China-made vehicl","content":"<p>Production output for Tesla in China has reportedly once again been halted and is being (once again) blamed on the global semiconductor shortage.</p>\n<p>Short of the pandemic, the semi shortage has become a very convenient scapegoat, especially for the auto industry, for numerous manufacturers who have shut down production temporarily and idled plants throughout 2021.</p>\n<p>Tesla's Shanghai plant was halted \"for about four days\" in August, according to anew report from Reuters.</p>\n<p>Production is reportedly now \"back to normal\" and the halt was blamed on shortages with the availability of electronic control units, mainly for the company's Model Y.</p>\n<p><img src=\"https://static.tigerbbs.com/088a74e39307bb5a626cdf7ae62f75c0\" tg-width=\"532\" tg-height=\"300\" width=\"100%\" height=\"auto\">In China, Tesla sold 32,968 China-made vehicles in July - this includes vehicles sold in China and vehicles exported - according to the China Passenger Car Association (CPCA). This was below the 33,155 vehicles sold in June; a number that we pointed out could have been a sign that the ship had steadied between Tesla and China - and that demand was once again rising.</p>\n<p>But July's numbers seem to indicate little, if any, growth in demand between June and July.</p>\n<p>Shipments of locally made vehicles sold in China plunged, to 8,621 cars from 28,138 in June. There is generally cyclicality for automaker sales wherein the beginning of a quarter (July) comes in markedly lower than the end of the previous quarter (June).</p>\n<p><img src=\"https://static.tigerbbs.com/100cff92002adb2ace977d6b7234a6b4\" tg-width=\"660\" tg-height=\"393\" width=\"100%\" height=\"auto\">PCA Secretary General Cui Dongshu said during a briefing last month: “Tesla tends to be aggressive in exports regardless of the domestic market in July. The fact that Tesla’s domestic deliveries didn’t reach 10,000 is normal and fine.”</p>\n<p>24,347 of the 32,968 cars made in China were manufactured for export.</p>\n<p>Tesla fell between BYD, who sold 50,387 China-made EVs and GM/SAIC, who sold 27.347 EVs.</p>\n<p>Recall, other automakers have slowed production due to the semi shortage, too. Wereported last monththat Toyota had slashed&nbsp;global production for September by 40% from its previous outlook. The production cut will reduce Toyota's global production for September from 900,000 automobiles to 500,000.</p>\n<p>As a result,&nbsp;Toyota's global production for the month will be below that of last September,&nbsp;when demand was beginning to recover from the initial stages of the coronavirus pandemic and Toyota turned out 840,000 units.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla Halted Production In China For 4 Days In August Due To The Semiconductor Shortage</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla Halted Production In China For 4 Days In August Due To The Semiconductor Shortage\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-03 08:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.zerohedge.com/markets/tesla-halted-production-china-4-days-august-due-semiconductor-shortage?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+zerohedge%2Ffeed+%28zero+hedge+-+on+a+long+enough+timeline%2C+the+survival+rate+for+everyone+drops+to+zero%29><strong>zerohedge</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Production output for Tesla in China has reportedly once again been halted and is being (once again) blamed on the global semiconductor shortage.\nShort of the pandemic, the semi shortage has become a ...</p>\n\n<a href=\"https://www.zerohedge.com/markets/tesla-halted-production-china-4-days-august-due-semiconductor-shortage?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+zerohedge%2Ffeed+%28zero+hedge+-+on+a+long+enough+timeline%2C+the+survival+rate+for+everyone+drops+to+zero%29\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.zerohedge.com/markets/tesla-halted-production-china-4-days-august-due-semiconductor-shortage?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+zerohedge%2Ffeed+%28zero+hedge+-+on+a+long+enough+timeline%2C+the+survival+rate+for+everyone+drops+to+zero%29","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1103995208","content_text":"Production output for Tesla in China has reportedly once again been halted and is being (once again) blamed on the global semiconductor shortage.\nShort of the pandemic, the semi shortage has become a very convenient scapegoat, especially for the auto industry, for numerous manufacturers who have shut down production temporarily and idled plants throughout 2021.\nTesla's Shanghai plant was halted \"for about four days\" in August, according to anew report from Reuters.\nProduction is reportedly now \"back to normal\" and the halt was blamed on shortages with the availability of electronic control units, mainly for the company's Model Y.\nIn China, Tesla sold 32,968 China-made vehicles in July - this includes vehicles sold in China and vehicles exported - according to the China Passenger Car Association (CPCA). This was below the 33,155 vehicles sold in June; a number that we pointed out could have been a sign that the ship had steadied between Tesla and China - and that demand was once again rising.\nBut July's numbers seem to indicate little, if any, growth in demand between June and July.\nShipments of locally made vehicles sold in China plunged, to 8,621 cars from 28,138 in June. There is generally cyclicality for automaker sales wherein the beginning of a quarter (July) comes in markedly lower than the end of the previous quarter (June).\nPCA Secretary General Cui Dongshu said during a briefing last month: “Tesla tends to be aggressive in exports regardless of the domestic market in July. The fact that Tesla’s domestic deliveries didn’t reach 10,000 is normal and fine.”\n24,347 of the 32,968 cars made in China were manufactured for export.\nTesla fell between BYD, who sold 50,387 China-made EVs and GM/SAIC, who sold 27.347 EVs.\nRecall, other automakers have slowed production due to the semi shortage, too. Wereported last monththat Toyota had slashed global production for September by 40% from its previous outlook. The production cut will reduce Toyota's global production for September from 900,000 automobiles to 500,000.\nAs a result, Toyota's global production for the month will be below that of last September, when demand was beginning to recover from the initial stages of the coronavirus pandemic and Toyota turned out 840,000 units.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":2872,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":812091480,"gmtCreate":1630540235140,"gmtModify":1676530332318,"author":{"id":"4087614954520500","authorId":"4087614954520500","name":"TANY0051","avatar":"https://static.tigerbbs.com/45437e79e37475d2911f2a4b2f84983d","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087614954520500","idStr":"4087614954520500"},"themes":[],"htmlText":"Way to go","listText":"Way to go","text":"Way to go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/812091480","repostId":"2164481914","repostType":4,"isVote":1,"tweetType":1,"viewCount":3034,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":818763729,"gmtCreate":1630450761361,"gmtModify":1676530304123,"author":{"id":"4087614954520500","authorId":"4087614954520500","name":"TANY0051","avatar":"https://static.tigerbbs.com/45437e79e37475d2911f2a4b2f84983d","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087614954520500","idStr":"4087614954520500"},"themes":[],"htmlText":"Go go go","listText":"Go go go","text":"Go go go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/818763729","repostId":"1165958269","repostType":4,"repost":{"id":"1165958269","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1630418022,"share":"https://ttm.financial/m/news/1165958269?lang=en_US&edition=fundamental","pubTime":"2021-08-31 21:53","market":"us","language":"en","title":"Moderna shares rose more than 2% in early trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1165958269","media":"Tiger Newspress","summary":"Moderna shares rose more than 2% in early trading.\n\n\nA study examining the immune response of Modern","content":"<p>Moderna&nbsp;shares&nbsp;rose&nbsp;more&nbsp;than&nbsp;2%&nbsp;in&nbsp;early&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/e3a6617d6ec5a20d69a181840ef582fb\" tg-width=\"885\" tg-height=\"634\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li>A study examining the immune response of Moderna's&nbsp;COVID-19 vaccine to Pfizer&nbsp;/BioNTech's&nbsp;found that the former created more than twice as many antibodies as the latter.</li>\n <li>The study, published in the<i>Journal of the American Medical Association</i>, examined 2,499 health care workers in Belgium inoculated with one of the two vaccines.</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna shares rose more than 2% in early trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna shares rose more than 2% in early trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-31 21:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Moderna&nbsp;shares&nbsp;rose&nbsp;more&nbsp;than&nbsp;2%&nbsp;in&nbsp;early&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/e3a6617d6ec5a20d69a181840ef582fb\" tg-width=\"885\" tg-height=\"634\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li>A study examining the immune response of Moderna's&nbsp;COVID-19 vaccine to Pfizer&nbsp;/BioNTech's&nbsp;found that the former created more than twice as many antibodies as the latter.</li>\n <li>The study, published in the<i>Journal of the American Medical Association</i>, examined 2,499 health care workers in Belgium inoculated with one of the two vaccines.</li>\n</ul>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","MRNA":"Moderna, Inc.","PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1165958269","content_text":"Moderna shares rose more than 2% in early trading.\n\n\nA study examining the immune response of Moderna's COVID-19 vaccine to Pfizer /BioNTech's found that the former created more than twice as many antibodies as the latter.\nThe study, published in theJournal of the American Medical Association, examined 2,499 health care workers in Belgium inoculated with one of the two vaccines.","news_type":1,"symbols_score_info":{"BNTX":0.9,"MRNA":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":4015,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":811732530,"gmtCreate":1630346258720,"gmtModify":1676530276920,"author":{"id":"4087614954520500","authorId":"4087614954520500","name":"TANY0051","avatar":"https://static.tigerbbs.com/45437e79e37475d2911f2a4b2f84983d","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087614954520500","idStr":"4087614954520500"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>Go go go","listText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>Go go go","text":"$Tesla Motors(TSLA)$Go go go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/811732530","isVote":1,"tweetType":1,"viewCount":1240,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":810456821,"gmtCreate":1629995566263,"gmtModify":1676530196849,"author":{"id":"4087614954520500","authorId":"4087614954520500","name":"TANY0051","avatar":"https://static.tigerbbs.com/45437e79e37475d2911f2a4b2f84983d","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087614954520500","idStr":"4087614954520500"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/810456821","repostId":"2162057566","repostType":4,"repost":{"id":"2162057566","kind":"highlight","pubTimestamp":1629961583,"share":"https://ttm.financial/m/news/2162057566?lang=en_US&edition=fundamental","pubTime":"2021-08-26 15:06","market":"us","language":"en","title":"The S&P 500 will keep going up this fall — for these 9 reasons","url":"https://stock-news.laohu8.com/highlight/detail?id=2162057566","media":"MarketWatch","summary":"Despite chatter of a stock-market top, there is no proof a correction is ‘overdue’\nGETTY IMAGES\nTher","content":"<p>Despite chatter of a stock-market top, there is no proof a correction is ‘overdue’</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b365930d049715a4e419b13d73249376\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>GETTY IMAGES</span></p>\n<p>There are plenty of absurd arguments that investors make to justify their positions. But one that is particularly maddening to me is the notion that the stock market can ever be “ready” for a correction.</p>\n<p>Not only is there an abundance of research that proves the folly of market timing to avoid downturns, but such statements seem to indicate you can easily predict market moves in general — and all you have to do is identify the forecast and you can ensure you’re early rather than late to a trend.</p>\n<p>As we all know, particularly after the remarkable COVID-19 disruptions and equally remarkable snap-back rally, there are never any certainties on Wall Street. So before you stick a fork in the current rally and write it off as overdone, here are plenty of reasons to stay fully invested — and to expect the current rally for stocks to keep rolling through year-end.</p>\n<p><b>Strong momentum for stocks:</b>In case you missed it, the S&amp;P 500 index&nbsp;has just notched its&nbsp;fastest doubling&nbsp;in history as it has surged from lows of around 2,240 on March 23 to around 4,500 in August. It also already has set 50 closing records this year. This kind of record-breaking momentum clearly can’t last forever, but it is important not to conflate this strong performance with the assumption a correction is “overdue.” Generally speaking, stocks tend to move higher simply because they’re moving higher — not suddenly crash out of the blue.</p>\n<p><b>Earnings remain impressive:</b>Companies across the S&amp;P 500 have beat estimates by an average of&nbsp;more than 19%&nbsp;in the last five quarters. This has fueled a lot of the gains we’ve seen for stocks. Take tech darling Nvidia,which just popped about 14% in a week on a&nbsp;strong earnings beat, or sporting retailer Dick’s Sporting Goods,which surged about&nbsp;20%&nbsp;in a single session after its strong report this week. Sentiment and technical indicators aside, it’s hard to argue that there’s not true improvement in fundamentals behind this recent run for stocks.</p>\n<p><b>Fed tapering fears abate:</b>One of the bearish arguments some investors have had in 2021 is that the U.S. Federal Reserve is&nbsp;considering tapering&nbsp;stimulus efforts that include $120 billion in monthly bond purchases by the central bank, among other things. However,most reports&nbsp;indicate any such stimulus drawdown will not occur in the near term — perhaps not until November at the earliest. That may sound like bad news for those who are more hawkish on monetary policy, but it is undeniable good news for near-term market dynamics.</p>\n<p><b>Wall Street remains bullish:</b>According to&nbsp;recent data, roughly 56% of analyst recommendations on S&amp;P 500 stocks are “buy” or equivalent. That’s the most since 2002 and a sign that there is continued upside for the stock market even after an already impressive run. There’s no guarantee that the so-called “smart-money” is correct, of course, but it’s an important indicator nevertheless.</p>\n<p><b>Housing market “wealth effect”:</b>Generally speaking, the typical American doesn’t have the majority of its wealth tied up in stocks. Rather,their home&nbsp;represents as much as two-thirds of their total assets — and as a result, their general perceptions of the economy and the investing environment tend to be colored by real estate more than anything else. That’s particularly good news in 2021 as housing prices continue to surge; in July, median home prices were up an impressive&nbsp;18.4%&nbsp;over the prior year. That “wealth affect” can will go a long way toward supporting spending and investment sentiment in the months ahead.</p>\n<p><b>Core inflation vs. food and energy:</b>It’s important to acknowledge that the chatter about inflation risks in 2021 often don’t include the full story. In July, the year-on-year inflation rate in the U.S. remained at a 20-year high of 5.4%, but when you skip food and energy prices that are historically quite volatile, the “core” monthly rate of inflation was just&nbsp;0.3% in July&nbsp;— which isn’t just modest but below expectations of a 0.4% gain.</p>\n<p><b>Bigger picture, inflation doesn’t equal a bear market anyway:</b>It’s also worth pointing out there is little direct correlation between relatively high inflation and relative low rates of returns for U.S. stocks. Take 2011, when headline inflation threatened to hit a&nbsp;4% rate&nbsp;(again, driven largely by food and energy) and some investors feared that would upend the recovery from the 2008-2009 financial crisis. There was assuredly volatility that year, but stocks hung tough. The S&amp;P 500 moved a few percentage points higher on the year — then gained nearly 15% in 2012 the following year.</p>\n<p><b>What’s the alternative now?:</b>Despite inflationary talk, hard assets like gold haven’t been that great of a bet for investors looking to grow their nest egg. SPDR Gold Shares,the most liquid physical gold-backed fund out there, is actually in the red over the lasts 12 months and down about 5% from its May peak. And lest you think the bond market is safe, major bond fund iShares 20+ Year Treasury Bond ETF&nbsp;is actually down 10% in the last year — even as yields have rolled back from their spring highs. Gold or bonds may be nice hedges or insurance policies, but where else other than stocks can investors actually access growth on Wall Street right now?</p>\n<p><b>Most investors should ignore short-term trends anyhow:</b>All of the above is based on the most recent headlines and trends. But for most investors, it pays to ignore those trends and stick with a long-term plan. According to&nbsp;Goldman Sachs research, stock market returns have averaged&nbsp;9.2%&nbsp;per over the past 140 years. Sure, there are always a few extra bad years along the way — but if you stay invested long enough, you’re almost certain to come out significantly ahead. Keep that in mind before you try to time the next potential bear market because of short-term volatility fears.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The S&P 500 will keep going up this fall — for these 9 reasons</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe S&P 500 will keep going up this fall — for these 9 reasons\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-26 15:06 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/the-s-p-500-will-keep-going-up-this-fall-for-these-9-reasons-11629911414?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Despite chatter of a stock-market top, there is no proof a correction is ‘overdue’\nGETTY IMAGES\nThere are plenty of absurd arguments that investors make to justify their positions. But one that is ...</p>\n\n<a href=\"https://www.marketwatch.com/story/the-s-p-500-will-keep-going-up-this-fall-for-these-9-reasons-11629911414?mod=home-page\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OEX":"标普100",".IXIC":"NASDAQ Composite","SPXU":"三倍做空标普500ETF-ProShares","SH":"做空标普500-Proshares","SDS":"两倍做空标普500 ETF-ProShares","SPY":"标普500ETF","UPRO":"三倍做多标普500ETF-ProShares","SSO":"2倍做多标普500ETF-ProShares",".DJI":"道琼斯","OEF":"标普100指数ETF-iShares",".SPX":"S&P 500 Index","IVV":"标普500ETF-iShares"},"source_url":"https://www.marketwatch.com/story/the-s-p-500-will-keep-going-up-this-fall-for-these-9-reasons-11629911414?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2162057566","content_text":"Despite chatter of a stock-market top, there is no proof a correction is ‘overdue’\nGETTY IMAGES\nThere are plenty of absurd arguments that investors make to justify their positions. But one that is particularly maddening to me is the notion that the stock market can ever be “ready” for a correction.\nNot only is there an abundance of research that proves the folly of market timing to avoid downturns, but such statements seem to indicate you can easily predict market moves in general — and all you have to do is identify the forecast and you can ensure you’re early rather than late to a trend.\nAs we all know, particularly after the remarkable COVID-19 disruptions and equally remarkable snap-back rally, there are never any certainties on Wall Street. So before you stick a fork in the current rally and write it off as overdone, here are plenty of reasons to stay fully invested — and to expect the current rally for stocks to keep rolling through year-end.\nStrong momentum for stocks:In case you missed it, the S&P 500 index has just notched its fastest doubling in history as it has surged from lows of around 2,240 on March 23 to around 4,500 in August. It also already has set 50 closing records this year. This kind of record-breaking momentum clearly can’t last forever, but it is important not to conflate this strong performance with the assumption a correction is “overdue.” Generally speaking, stocks tend to move higher simply because they’re moving higher — not suddenly crash out of the blue.\nEarnings remain impressive:Companies across the S&P 500 have beat estimates by an average of more than 19% in the last five quarters. This has fueled a lot of the gains we’ve seen for stocks. Take tech darling Nvidia,which just popped about 14% in a week on a strong earnings beat, or sporting retailer Dick’s Sporting Goods,which surged about 20% in a single session after its strong report this week. Sentiment and technical indicators aside, it’s hard to argue that there’s not true improvement in fundamentals behind this recent run for stocks.\nFed tapering fears abate:One of the bearish arguments some investors have had in 2021 is that the U.S. Federal Reserve is considering tapering stimulus efforts that include $120 billion in monthly bond purchases by the central bank, among other things. However,most reports indicate any such stimulus drawdown will not occur in the near term — perhaps not until November at the earliest. That may sound like bad news for those who are more hawkish on monetary policy, but it is undeniable good news for near-term market dynamics.\nWall Street remains bullish:According to recent data, roughly 56% of analyst recommendations on S&P 500 stocks are “buy” or equivalent. That’s the most since 2002 and a sign that there is continued upside for the stock market even after an already impressive run. There’s no guarantee that the so-called “smart-money” is correct, of course, but it’s an important indicator nevertheless.\nHousing market “wealth effect”:Generally speaking, the typical American doesn’t have the majority of its wealth tied up in stocks. Rather,their home represents as much as two-thirds of their total assets — and as a result, their general perceptions of the economy and the investing environment tend to be colored by real estate more than anything else. That’s particularly good news in 2021 as housing prices continue to surge; in July, median home prices were up an impressive 18.4% over the prior year. That “wealth affect” can will go a long way toward supporting spending and investment sentiment in the months ahead.\nCore inflation vs. food and energy:It’s important to acknowledge that the chatter about inflation risks in 2021 often don’t include the full story. In July, the year-on-year inflation rate in the U.S. remained at a 20-year high of 5.4%, but when you skip food and energy prices that are historically quite volatile, the “core” monthly rate of inflation was just 0.3% in July — which isn’t just modest but below expectations of a 0.4% gain.\nBigger picture, inflation doesn’t equal a bear market anyway:It’s also worth pointing out there is little direct correlation between relatively high inflation and relative low rates of returns for U.S. stocks. Take 2011, when headline inflation threatened to hit a 4% rate (again, driven largely by food and energy) and some investors feared that would upend the recovery from the 2008-2009 financial crisis. There was assuredly volatility that year, but stocks hung tough. The S&P 500 moved a few percentage points higher on the year — then gained nearly 15% in 2012 the following year.\nWhat’s the alternative now?:Despite inflationary talk, hard assets like gold haven’t been that great of a bet for investors looking to grow their nest egg. SPDR Gold Shares,the most liquid physical gold-backed fund out there, is actually in the red over the lasts 12 months and down about 5% from its May peak. And lest you think the bond market is safe, major bond fund iShares 20+ Year Treasury Bond ETF is actually down 10% in the last year — even as yields have rolled back from their spring highs. Gold or bonds may be nice hedges or insurance policies, but where else other than stocks can investors actually access growth on Wall Street right now?\nMost investors should ignore short-term trends anyhow:All of the above is based on the most recent headlines and trends. But for most investors, it pays to ignore those trends and stick with a long-term plan. According to Goldman Sachs research, stock market returns have averaged 9.2% per over the past 140 years. Sure, there are always a few extra bad years along the way — but if you stay invested long enough, you’re almost certain to come out significantly ahead. Keep that in mind before you try to time the next potential bear market because of short-term volatility fears.","news_type":1,"symbols_score_info":{"OEX":0.9,"SSO":0.9,"OEF":0.9,"ESmain":0.9,".DJI":0.9,"SPY":0.9,"SPXU":0.9,"SH":0.9,"UPRO":0.9,".SPX":0.9,".IXIC":0.9,"SDS":0.9,"IVV":0.9}},"isVote":1,"tweetType":1,"viewCount":1559,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":810525704,"gmtCreate":1629987604508,"gmtModify":1676530194163,"author":{"id":"4087614954520500","authorId":"4087614954520500","name":"TANY0051","avatar":"https://static.tigerbbs.com/45437e79e37475d2911f2a4b2f84983d","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087614954520500","idStr":"4087614954520500"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/INO\">$Inovio Pharmaceuticals(INO)$</a>Go go go","listText":"<a href=\"https://laohu8.com/S/INO\">$Inovio Pharmaceuticals(INO)$</a>Go go go","text":"$Inovio Pharmaceuticals(INO)$Go go go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/810525704","isVote":1,"tweetType":1,"viewCount":843,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":837542027,"gmtCreate":1629901914469,"gmtModify":1676530167819,"author":{"id":"4087614954520500","authorId":"4087614954520500","name":"TANY0051","avatar":"https://static.tigerbbs.com/45437e79e37475d2911f2a4b2f84983d","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087614954520500","idStr":"4087614954520500"},"themes":[],"htmlText":"Way to go","listText":"Way to go","text":"Way to go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/837542027","repostId":"2162051949","repostType":4,"repost":{"id":"2162051949","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1629899991,"share":"https://ttm.financial/m/news/2162051949?lang=en_US&edition=fundamental","pubTime":"2021-08-25 21:59","market":"us","language":"en","title":"Moderna shares surged 4% in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2162051949","media":"Tiger Newspress","summary":"Moderna shares surged 4% in morning trading on completing submission of BLA to U.S. Food and Drug Ad","content":"<p>Moderna shares surged 4% in morning trading&nbsp;on&nbsp;completing submission of BLA to U.S. Food and Drug Administration for its COVID-19 Vaccine.</p>\n<p><img src=\"https://static.tigerbbs.com/333b7cf1e02c99fd0d5925c7c1931da0\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>\n<p><a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a> (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced it has completed the rolling submission process for its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the full licensure of the Moderna COVID-19 Vaccine for active immunization to prevent COVID-19 in individuals 18 years of age and older. As part of the completed BLA submission, Moderna has requested Priority Review designation.</p>\n<p>“This BLA submission for our COVID-19 vaccine, which we began in June, is an important milestone in our battle against COVID-19 and for Moderna, as this is the first BLA submission in our company’s history,” said Stéphane Bancel, Chief Executive Officer of Moderna. “We are pleased that our COVID-19 vaccine is showing durable efficacy of 93% through six months after dose 2. I want to thank the people who participated in our clinical studies, as well as the staff at clinical trial sites who have been on the front lines of the fight against the virus. I would again like to thank our partners at NIH, NIAID and BARDA who have helped us advance the clinical development of our mRNA COVID-19 vaccine. I would also like to thank the U.S. FDA for their hard work and guidance through the BLA submission process and the entire Moderna team for their relentlessness in pursuing our mission of delivering on the promise of mRNA science.”</p>\n<p>The FDA Fast Track designation received on May 12, 2020 has permitted Moderna to submit sections of the BLA on a rolling basis and Moderna announced the initiation of the BLA submission on June 1, 2021. The completed submission includes clinical data from the Phase 3 COVE study of the Moderna COVID-19 vaccine, which enrolled more than 30,000 participants in the U.S. and was conducted in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), and the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services. In final analysis of Phase 3 COVE study data, the Moderna COVID-19 vaccine showed 93% efficacy, with the efficacy remaining durable through six months after administration of the second dose. In the COVE study, reported adverse reactions included pain at the injection site, fatigue, headache, myalgia, arthralgia, chills, nausea/vomiting, axillary swelling/tenderness, fever, swelling at the injection site, and erythema at the injection site.</p>\n<p>The Moderna COVID-19 vaccine is currently available in the U.S. for individuals 18 years of age and older under an Emergency Use Authorization (EUA) granted by the FDA on December 18, 2020. Since then, Moderna has released more than 300 million doses of the vaccine to the U.S. government.</p>\n<p>Moderna has also filed for an Emergency Use Authorization (EUA) for adolescents ages 12 and above with the U.S. FDA.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna shares surged 4% in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna shares surged 4% in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-25 21:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Moderna shares surged 4% in morning trading&nbsp;on&nbsp;completing submission of BLA to U.S. Food and Drug Administration for its COVID-19 Vaccine.</p>\n<p><img src=\"https://static.tigerbbs.com/333b7cf1e02c99fd0d5925c7c1931da0\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>\n<p><a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a> (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced it has completed the rolling submission process for its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the full licensure of the Moderna COVID-19 Vaccine for active immunization to prevent COVID-19 in individuals 18 years of age and older. As part of the completed BLA submission, Moderna has requested Priority Review designation.</p>\n<p>“This BLA submission for our COVID-19 vaccine, which we began in June, is an important milestone in our battle against COVID-19 and for Moderna, as this is the first BLA submission in our company’s history,” said Stéphane Bancel, Chief Executive Officer of Moderna. “We are pleased that our COVID-19 vaccine is showing durable efficacy of 93% through six months after dose 2. I want to thank the people who participated in our clinical studies, as well as the staff at clinical trial sites who have been on the front lines of the fight against the virus. I would again like to thank our partners at NIH, NIAID and BARDA who have helped us advance the clinical development of our mRNA COVID-19 vaccine. I would also like to thank the U.S. FDA for their hard work and guidance through the BLA submission process and the entire Moderna team for their relentlessness in pursuing our mission of delivering on the promise of mRNA science.”</p>\n<p>The FDA Fast Track designation received on May 12, 2020 has permitted Moderna to submit sections of the BLA on a rolling basis and Moderna announced the initiation of the BLA submission on June 1, 2021. The completed submission includes clinical data from the Phase 3 COVE study of the Moderna COVID-19 vaccine, which enrolled more than 30,000 participants in the U.S. and was conducted in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), and the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services. In final analysis of Phase 3 COVE study data, the Moderna COVID-19 vaccine showed 93% efficacy, with the efficacy remaining durable through six months after administration of the second dose. In the COVE study, reported adverse reactions included pain at the injection site, fatigue, headache, myalgia, arthralgia, chills, nausea/vomiting, axillary swelling/tenderness, fever, swelling at the injection site, and erythema at the injection site.</p>\n<p>The Moderna COVID-19 vaccine is currently available in the U.S. for individuals 18 years of age and older under an Emergency Use Authorization (EUA) granted by the FDA on December 18, 2020. Since then, Moderna has released more than 300 million doses of the vaccine to the U.S. government.</p>\n<p>Moderna has also filed for an Emergency Use Authorization (EUA) for adolescents ages 12 and above with the U.S. FDA.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2162051949","content_text":"Moderna shares surged 4% in morning trading on completing submission of BLA to U.S. Food and Drug Administration for its COVID-19 Vaccine.\n\nModerna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced it has completed the rolling submission process for its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the full licensure of the Moderna COVID-19 Vaccine for active immunization to prevent COVID-19 in individuals 18 years of age and older. As part of the completed BLA submission, Moderna has requested Priority Review designation.\n“This BLA submission for our COVID-19 vaccine, which we began in June, is an important milestone in our battle against COVID-19 and for Moderna, as this is the first BLA submission in our company’s history,” said Stéphane Bancel, Chief Executive Officer of Moderna. “We are pleased that our COVID-19 vaccine is showing durable efficacy of 93% through six months after dose 2. I want to thank the people who participated in our clinical studies, as well as the staff at clinical trial sites who have been on the front lines of the fight against the virus. I would again like to thank our partners at NIH, NIAID and BARDA who have helped us advance the clinical development of our mRNA COVID-19 vaccine. I would also like to thank the U.S. FDA for their hard work and guidance through the BLA submission process and the entire Moderna team for their relentlessness in pursuing our mission of delivering on the promise of mRNA science.”\nThe FDA Fast Track designation received on May 12, 2020 has permitted Moderna to submit sections of the BLA on a rolling basis and Moderna announced the initiation of the BLA submission on June 1, 2021. The completed submission includes clinical data from the Phase 3 COVE study of the Moderna COVID-19 vaccine, which enrolled more than 30,000 participants in the U.S. and was conducted in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), and the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services. In final analysis of Phase 3 COVE study data, the Moderna COVID-19 vaccine showed 93% efficacy, with the efficacy remaining durable through six months after administration of the second dose. In the COVE study, reported adverse reactions included pain at the injection site, fatigue, headache, myalgia, arthralgia, chills, nausea/vomiting, axillary swelling/tenderness, fever, swelling at the injection site, and erythema at the injection site.\nThe Moderna COVID-19 vaccine is currently available in the U.S. for individuals 18 years of age and older under an Emergency Use Authorization (EUA) granted by the FDA on December 18, 2020. Since then, Moderna has released more than 300 million doses of the vaccine to the U.S. government.\nModerna has also filed for an Emergency Use Authorization (EUA) for adolescents ages 12 and above with the U.S. FDA.","news_type":1,"symbols_score_info":{"MRNA":0.9}},"isVote":1,"tweetType":1,"viewCount":869,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":833923153,"gmtCreate":1629198954172,"gmtModify":1676529963042,"author":{"id":"4087614954520500","authorId":"4087614954520500","name":"TANY0051","avatar":"https://static.tigerbbs.com/45437e79e37475d2911f2a4b2f84983d","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087614954520500","idStr":"4087614954520500"},"themes":[],"htmlText":"[Sad]&nbsp;","listText":"[Sad]&nbsp;","text":"[Sad]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/833923153","repostId":"1197491379","repostType":4,"isVote":1,"tweetType":1,"viewCount":1009,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":833929753,"gmtCreate":1629198932072,"gmtModify":1676529963021,"author":{"id":"4087614954520500","authorId":"4087614954520500","name":"TANY0051","avatar":"https://static.tigerbbs.com/45437e79e37475d2911f2a4b2f84983d","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087614954520500","idStr":"4087614954520500"},"themes":[],"htmlText":"[Sad]&nbsp;","listText":"[Sad]&nbsp;","text":"[Sad]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/833929753","repostId":"1163960572","repostType":4,"repost":{"id":"1163960572","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1629187531,"share":"https://ttm.financial/m/news/1163960572?lang=en_US&edition=fundamental","pubTime":"2021-08-17 16:05","market":"us","language":"en","title":"China Tech Stocks Slump as Nation Issues Draft Competition Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=1163960572","media":"Tiger Newspress","summary":" A wave of selling in China’s bellwether technology stocks continued for a fifth day, following Beijing’s latest moves to tighten its grip on the nation’s internet giants.China tech stocks slump in premarket trading, after China’s market regulator issued draft rules banning unfair competition among the nation’s online platform operators.The wide-ranging proposals released Tuesday come after the tech-industry ministry launched a campaign last month aimed at rooting out a raft of problematic behav","content":"<p>(Aug 17)&nbsp;A wave of selling in China’s bellwether technology stocks continued for a fifth day, following Beijing’s latest moves to tighten its grip on the nation’s internet giants.</p>\n<p>China tech stocks slump in premarket trading, after China’s market regulator issued draft rules banning unfair competition among the nation’s online platform operators.</p>\n<p>Baidu Inc.&nbsp;fell more than&nbsp;2% while&nbsp;Alibaba Group Holding Ltd.&nbsp;dropped by at least 3%. That followed Monday’sselloffin Chinese online game firms in the wake of state media criticism of the sector, which spilled over into U.S. trading&nbsp;overnight&nbsp;as the Securities and Exchange Commissionwarnedabout the risks of investing in Chinese stocks.</p>\n<p><img src=\"https://static.tigerbbs.com/6ad16a2d4c06459a94762f22c1916b01\" tg-width=\"371\" tg-height=\"683\" referrerpolicy=\"no-referrer\">The wide-ranging proposals released Tuesday come after the tech-industry ministry launched a campaign last month aimed at rooting out a raft of&nbsp;problematic&nbsp;behavior. It follows moves by Beijing to rein in the country’s internet leaders in areas from antitrust to data security and ride-hailing.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China Tech Stocks Slump as Nation Issues Draft Competition Rules</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina Tech Stocks Slump as Nation Issues Draft Competition Rules\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-17 16:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Aug 17)&nbsp;A wave of selling in China’s bellwether technology stocks continued for a fifth day, following Beijing’s latest moves to tighten its grip on the nation’s internet giants.</p>\n<p>China tech stocks slump in premarket trading, after China’s market regulator issued draft rules banning unfair competition among the nation’s online platform operators.</p>\n<p>Baidu Inc.&nbsp;fell more than&nbsp;2% while&nbsp;Alibaba Group Holding Ltd.&nbsp;dropped by at least 3%. That followed Monday’sselloffin Chinese online game firms in the wake of state media criticism of the sector, which spilled over into U.S. trading&nbsp;overnight&nbsp;as the Securities and Exchange Commissionwarnedabout the risks of investing in Chinese stocks.</p>\n<p><img src=\"https://static.tigerbbs.com/6ad16a2d4c06459a94762f22c1916b01\" tg-width=\"371\" tg-height=\"683\" referrerpolicy=\"no-referrer\">The wide-ranging proposals released Tuesday come after the tech-industry ministry launched a campaign last month aimed at rooting out a raft of&nbsp;problematic&nbsp;behavior. It follows moves by Beijing to rein in the country’s internet leaders in areas from antitrust to data security and ride-hailing.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1163960572","content_text":"(Aug 17) A wave of selling in China’s bellwether technology stocks continued for a fifth day, following Beijing’s latest moves to tighten its grip on the nation’s internet giants.\nChina tech stocks slump in premarket trading, after China’s market regulator issued draft rules banning unfair competition among the nation’s online platform operators.\nBaidu Inc. fell more than 2% while Alibaba Group Holding Ltd. dropped by at least 3%. That followed Monday’sselloffin Chinese online game firms in the wake of state media criticism of the sector, which spilled over into U.S. trading overnight as the Securities and Exchange Commissionwarnedabout the risks of investing in Chinese stocks.\nThe wide-ranging proposals released Tuesday come after the tech-industry ministry launched a campaign last month aimed at rooting out a raft of problematic behavior. It follows moves by Beijing to rein in the country’s internet leaders in areas from antitrust to data security and ride-hailing.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":904,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":897039454,"gmtCreate":1628862213778,"gmtModify":1676529878364,"author":{"id":"4087614954520500","authorId":"4087614954520500","name":"TANY0051","avatar":"https://static.tigerbbs.com/45437e79e37475d2911f2a4b2f84983d","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087614954520500","idStr":"4087614954520500"},"themes":[],"htmlText":"[Smile]&nbsp;","listText":"[Smile]&nbsp;","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/897039454","repostId":"1141206470","repostType":4,"repost":{"id":"1141206470","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628861824,"share":"https://ttm.financial/m/news/1141206470?lang=en_US&edition=fundamental","pubTime":"2021-08-13 21:37","market":"us","language":"en","title":"BioNTech, Moderna Rise On Nod To Booster For Those With Weak Immunity","url":"https://stock-news.laohu8.com/highlight/detail?id=1141206470","media":"Tiger Newspress","summary":"BioNTech and Moderna stocks were up in early trading following the FDA authorizing Covid-19 booster ","content":"<p>BioNTech&nbsp;and Moderna&nbsp;stocks were up in&nbsp;early&nbsp;trading following the FDA authorizing Covid-19 booster shots for people with weak immunity.</p>\n<p>BioNTech was up 3% and Moderna gained 3%, while Pfizer&nbsp;, which has jointly developed the two-dose mRNA vaccine with BioNTech, was up 2%.</p>\n<p><img src=\"https://static.tigerbbs.com/18d1d9877f2ba36a61eaf23f41b8914f\" tg-width=\"898\" tg-height=\"607\" referrerpolicy=\"no-referrer\"></p>\n<p>Late on Thursday, the U.S. Food and Drug Administration&nbsp;authorized a booster doseof vaccines from Pfizer Inc(PFE.N)and Moderna Inc(MRNA.O)for people with compromised immune systems.</p>\n<p>Pfizer, along with its German partner BioNTech , and Moderna have together locked up over $60 billion in sales of the shots just in 2021 and 2022. The agreements include supply of the initial two doses of their vaccines as well as billions of dollars in potential boosters for wealthy nations.</p>\n<p>Going forward, analysts have forecast revenue of over $6.6 billion for the Pfizer/BioNTech shot and $7.6 billion for Moderna in 2023, mostly from booster sales. They eventually see the annual market settling at around $5 billion or higher, with additional drugmakers competing for those sales.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioNTech, Moderna Rise On Nod To Booster For Those With Weak Immunity</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioNTech, Moderna Rise On Nod To Booster For Those With Weak Immunity\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-13 21:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BioNTech&nbsp;and Moderna&nbsp;stocks were up in&nbsp;early&nbsp;trading following the FDA authorizing Covid-19 booster shots for people with weak immunity.</p>\n<p>BioNTech was up 3% and Moderna gained 3%, while Pfizer&nbsp;, which has jointly developed the two-dose mRNA vaccine with BioNTech, was up 2%.</p>\n<p><img src=\"https://static.tigerbbs.com/18d1d9877f2ba36a61eaf23f41b8914f\" tg-width=\"898\" tg-height=\"607\" referrerpolicy=\"no-referrer\"></p>\n<p>Late on Thursday, the U.S. Food and Drug Administration&nbsp;authorized a booster doseof vaccines from Pfizer Inc(PFE.N)and Moderna Inc(MRNA.O)for people with compromised immune systems.</p>\n<p>Pfizer, along with its German partner BioNTech , and Moderna have together locked up over $60 billion in sales of the shots just in 2021 and 2022. The agreements include supply of the initial two doses of their vaccines as well as billions of dollars in potential boosters for wealthy nations.</p>\n<p>Going forward, analysts have forecast revenue of over $6.6 billion for the Pfizer/BioNTech shot and $7.6 billion for Moderna in 2023, mostly from booster sales. They eventually see the annual market settling at around $5 billion or higher, with additional drugmakers competing for those sales.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","PFE":"辉瑞","MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1141206470","content_text":"BioNTech and Moderna stocks were up in early trading following the FDA authorizing Covid-19 booster shots for people with weak immunity.\nBioNTech was up 3% and Moderna gained 3%, while Pfizer , which has jointly developed the two-dose mRNA vaccine with BioNTech, was up 2%.\n\nLate on Thursday, the U.S. Food and Drug Administration authorized a booster doseof vaccines from Pfizer Inc(PFE.N)and Moderna Inc(MRNA.O)for people with compromised immune systems.\nPfizer, along with its German partner BioNTech , and Moderna have together locked up over $60 billion in sales of the shots just in 2021 and 2022. The agreements include supply of the initial two doses of their vaccines as well as billions of dollars in potential boosters for wealthy nations.\nGoing forward, analysts have forecast revenue of over $6.6 billion for the Pfizer/BioNTech shot and $7.6 billion for Moderna in 2023, mostly from booster sales. They eventually see the annual market settling at around $5 billion or higher, with additional drugmakers competing for those sales.","news_type":1,"symbols_score_info":{"PFE":0.9,"BNTX":0.9,"MRNA":0.9}},"isVote":1,"tweetType":1,"viewCount":1312,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":892871397,"gmtCreate":1628651015119,"gmtModify":1676529809568,"author":{"id":"4087614954520500","authorId":"4087614954520500","name":"TANY0051","avatar":"https://static.tigerbbs.com/45437e79e37475d2911f2a4b2f84983d","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087614954520500","idStr":"4087614954520500"},"themes":[],"htmlText":"[Strong]&nbsp;","listText":"[Strong]&nbsp;","text":"[Strong]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/892871397","repostId":"1144336160","repostType":4,"isVote":1,"tweetType":1,"viewCount":967,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":892873506,"gmtCreate":1628650976505,"gmtModify":1676529809558,"author":{"id":"4087614954520500","authorId":"4087614954520500","name":"TANY0051","avatar":"https://static.tigerbbs.com/45437e79e37475d2911f2a4b2f84983d","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087614954520500","idStr":"4087614954520500"},"themes":[],"htmlText":"[Strong]&nbsp;","listText":"[Strong]&nbsp;","text":"[Strong]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/892873506","repostId":"1108124704","repostType":4,"repost":{"id":"1108124704","kind":"news","pubTimestamp":1628647585,"share":"https://ttm.financial/m/news/1108124704?lang=en_US&edition=fundamental","pubTime":"2021-08-11 10:06","market":"us","language":"en","title":"Tesla sales cratered in China, but investors don't seem to mind","url":"https://stock-news.laohu8.com/highlight/detail?id=1108124704","media":"CNN","summary":"New York (CNN Business)Tesla sales dropped sharply in China, according to a trade group report, sugg","content":"<p><a href=\"https://laohu8.com/S/NWY\">New York</a> (CNN Business)Tesla sales dropped sharply in <a href=\"https://laohu8.com/S/CAAS\">China</a>, according to a trade group report, suggesting it is losing ground in the world's largest market for both traditional and electric vehicles.</p>\n<p>The China Passenger Car Association reported that Tesla's sales in China fell to 8,621 cars in July, down nearly 70% from June. But the export of cars built at Tesla's Shanghai plant jumped to 24,347 for July, compared with 5,017 in June. That means total sales of Chinese-built Teslas fell less than 1% overall.Critics say the steep decline of sales to Chinese consumers is yet another sign of the growing problems the company faces in the country. Tesla is contending with increased competition from Chinese EV makers as well as a run of bad publicity, including arecallof virtually all of the cars that have been built in Shanghai. The company also facedprotests by Telsa owners at this year's Shanghai auto showover poor car quality and varioussafety concernsflagged by Chinese regulators.Teslas accounted for just 3.9% of July sales of battery electric vehicles in China, down from 12.6% in June, said analyst Gordon Johnson, who has been among the harshest critics of the company. He said that decline shows Tesla is facing fiercer competition from local EV startups.\"Overall, it now seems clear that Tesla has overbuilt Chinese capacity when compared to domestic demand, which will result in further price cuts and margin pressure,\" Johnson said. \"Given China is supposed to be Tesla's 'growth market,' these numbers should concern any Tesla bull.\"ButTesla(TSLA)investors seemed unfazed by the sales dip, as shares declined less than 2% in early trading Tuesday. That's in sharp contrast to the steeper drops in the stock price following similarweak reportsfrom the CPCA in April and May.</p>\n<p>Last month investors saw that declining numbers in China didn't stop Tesla from reportingbetter than expected global salesfor the full quarter, said Dan Ives, a tech analyst for Wedbush Securities and a Tesla bull.\"I think investors are becoming less sensitive to the month-to-month China numbers,\" he said. \"Ultimately, it's not been the best indicator of Tesla's success, as we saw in the second quarter.\"But Ives said that if Tesla's sales in China don't improve, the company could face serious problems going forward.</p>\n<p>\"Right now we believe that China will be 40% of deliveries for Tesla by next year,\" he said. \"So selling only 8,000 in a month, even though it's a volatile number, it doesn't give the bulls the warm and fuzzies.\"Unlike other automakers, Tesla does not breakdown sales by market and only reports sales quarterly, not monthly. So the numbers from the CPCA are not confirmed. Tesla did not respond to a request for comment Tuesday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla sales cratered in China, but investors don't seem to mind</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla sales cratered in China, but investors don't seem to mind\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-11 10:06 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://edition.cnn.com/2021/08/10/investing/tesla-china-sales/index.html><strong>CNN</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>New York (CNN Business)Tesla sales dropped sharply in China, according to a trade group report, suggesting it is losing ground in the world's largest market for both traditional and electric vehicles....</p>\n\n<a href=\"https://edition.cnn.com/2021/08/10/investing/tesla-china-sales/index.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://edition.cnn.com/2021/08/10/investing/tesla-china-sales/index.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108124704","content_text":"New York (CNN Business)Tesla sales dropped sharply in China, according to a trade group report, suggesting it is losing ground in the world's largest market for both traditional and electric vehicles.\nThe China Passenger Car Association reported that Tesla's sales in China fell to 8,621 cars in July, down nearly 70% from June. But the export of cars built at Tesla's Shanghai plant jumped to 24,347 for July, compared with 5,017 in June. That means total sales of Chinese-built Teslas fell less than 1% overall.Critics say the steep decline of sales to Chinese consumers is yet another sign of the growing problems the company faces in the country. Tesla is contending with increased competition from Chinese EV makers as well as a run of bad publicity, including arecallof virtually all of the cars that have been built in Shanghai. The company also facedprotests by Telsa owners at this year's Shanghai auto showover poor car quality and varioussafety concernsflagged by Chinese regulators.Teslas accounted for just 3.9% of July sales of battery electric vehicles in China, down from 12.6% in June, said analyst Gordon Johnson, who has been among the harshest critics of the company. He said that decline shows Tesla is facing fiercer competition from local EV startups.\"Overall, it now seems clear that Tesla has overbuilt Chinese capacity when compared to domestic demand, which will result in further price cuts and margin pressure,\" Johnson said. \"Given China is supposed to be Tesla's 'growth market,' these numbers should concern any Tesla bull.\"ButTesla(TSLA)investors seemed unfazed by the sales dip, as shares declined less than 2% in early trading Tuesday. That's in sharp contrast to the steeper drops in the stock price following similarweak reportsfrom the CPCA in April and May.\nLast month investors saw that declining numbers in China didn't stop Tesla from reportingbetter than expected global salesfor the full quarter, said Dan Ives, a tech analyst for Wedbush Securities and a Tesla bull.\"I think investors are becoming less sensitive to the month-to-month China numbers,\" he said. \"Ultimately, it's not been the best indicator of Tesla's success, as we saw in the second quarter.\"But Ives said that if Tesla's sales in China don't improve, the company could face serious problems going forward.\n\"Right now we believe that China will be 40% of deliveries for Tesla by next year,\" he said. \"So selling only 8,000 in a month, even though it's a volatile number, it doesn't give the bulls the warm and fuzzies.\"Unlike other automakers, Tesla does not breakdown sales by market and only reports sales quarterly, not monthly. So the numbers from the CPCA are not confirmed. Tesla did not respond to a request for comment Tuesday.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":855,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":896858296,"gmtCreate":1628571212215,"gmtModify":1703508330688,"author":{"id":"4087614954520500","authorId":"4087614954520500","name":"TANY0051","avatar":"https://static.tigerbbs.com/45437e79e37475d2911f2a4b2f84983d","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087614954520500","idStr":"4087614954520500"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/D05.SI\">$DBS GROUP HOLDINGS LTD(D05.SI)$</a>[Strong]&nbsp;","listText":"<a href=\"https://laohu8.com/S/D05.SI\">$DBS GROUP HOLDINGS LTD(D05.SI)$</a>[Strong]&nbsp;","text":"$DBS GROUP HOLDINGS LTD(D05.SI)$[Strong]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/896858296","isVote":1,"tweetType":1,"viewCount":1081,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":9001945811,"gmtCreate":1641166307069,"gmtModify":1676533576900,"author":{"id":"4087614954520500","authorId":"4087614954520500","name":"TANY0051","avatar":"https://static.tigerbbs.com/45437e79e37475d2911f2a4b2f84983d","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087614954520500","idStr":"4087614954520500"},"themes":[],"htmlText":"Continue to create&nbsp;more good news in 2022.&nbsp;","listText":"Continue to create&nbsp;more good news in 2022.&nbsp;","text":"Continue to create more good news in 2022.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001945811","repostId":"2200544080","repostType":4,"isVote":1,"tweetType":1,"viewCount":3976,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":899511749,"gmtCreate":1628206028981,"gmtModify":1703502996785,"author":{"id":"4087614954520500","authorId":"4087614954520500","name":"TANY0051","avatar":"https://static.tigerbbs.com/45437e79e37475d2911f2a4b2f84983d","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087614954520500","idStr":"4087614954520500"},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/899511749","repostId":"2157456017","repostType":4,"repost":{"id":"2157456017","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1628204156,"share":"https://ttm.financial/m/news/2157456017?lang=en_US&edition=fundamental","pubTime":"2021-08-06 06:55","market":"us","language":"en","title":"Nasdaq, S&P 500, set records as jobless claims decline","url":"https://stock-news.laohu8.com/highlight/detail?id=2157456017","media":"Reuters","summary":"* Nasdaq, S&P 500 close at record highs\n* Layoff at lowest in over 21 years\n* Healthcare and materia","content":"<p>* Nasdaq, S&amp;P 500 close at record highs</p>\n<p>* Layoff at lowest in over 21 years</p>\n<p>* Healthcare and materials sectoral losers on S&amp;P 500</p>\n<p>Aug 5 (Reuters) - The Nasdaq and S&amp;P 500 closed at record levels on Thursday after a spate of strong corporate earnings and a further decline in U.S. unemployment claims last week, as investors weighed concerns of the surge of the Delta variant ahead of Friday's job's report.</p>\n<p>Initial claims for state unemployment benefits fell by 14,000 to 385,000 in the week ended July 31, while layoffs dropped to their lowest level in more than 21 years last month as companies held on to their workers amid a labor shortage, the Labor Department's report showed.</p>\n<p>\"The directional change has continued to be improving in the last few weeks and now it's a new low since beginning the pandemic,\" said Keith Buchanan, portfolio manager at Globalt Investments in Atlanta, Georgia. \"I think that's what (is) kind of leading to some optimism today and earnings to this point have been positive.\"</p>\n<p>Nine of the 11 major S&amp;P 500 sector indexes rose, with healthcare stocks in the red as Cigna Corp slipped 10.9% after predicting a bigger hit to full-year earnings from the pandemic.</p>\n<p>Focus will now shift to the jobs report for July on Friday. Analysts say a disappointing number might raise questions about an economic recovery, but it could also lead the Federal Reserve to remain accommodative.</p>\n<p>Meanwhile, Robinhood Markets Inc tumbled 27.6%, snapping a four-day rally fueled by interest from retail traders.</p>\n<p>ViacomCBS Inc jumped 7.1% as the company said it signed up the highest number of new streaming subscribers in the second quarter, and struck a multi-year deal with Comcast Corp's&nbsp;Sky to launch the Paramount+ streaming service in Europe.</p>\n<p>The Dow Jones Industrial Average rose 271.58 points, or 0.78%, to 35,064.25, the S&amp;P 500 gained 26.44 points, or 0.60%, to 4,429.1 and the Nasdaq Composite added 114.58 points, or 0.78%, to 14,895.12.</p>\n<p>Concerns about the pace of economic growth and higher inflation have pressured the S&amp;P 500 index, but stellar corporate earnings so far have put it on track to end the week higher.</p>\n<p>Fed Vice Chair Richard Clarida, a major architect of the central bank's new policy strategy, said on Wednesday he felt the conditions for raising interest rates could be met by the end of 2022.</p>\n<p>Volume on U.S. exchanges was 8.86 billion shares, compared with the 9.63 billion average for the full session over the last 20 trading days.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 2.06-to-1 ratio; on Nasdaq, a 2.26-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 52 new 52-week highs and 4 new lows; the Nasdaq Composite recorded 111 new highs and 103 new lows.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nasdaq, S&P 500, set records as jobless claims decline</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNasdaq, S&P 500, set records as jobless claims decline\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-06 06:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* Nasdaq, S&amp;P 500 close at record highs</p>\n<p>* Layoff at lowest in over 21 years</p>\n<p>* Healthcare and materials sectoral losers on S&amp;P 500</p>\n<p>Aug 5 (Reuters) - The Nasdaq and S&amp;P 500 closed at record levels on Thursday after a spate of strong corporate earnings and a further decline in U.S. unemployment claims last week, as investors weighed concerns of the surge of the Delta variant ahead of Friday's job's report.</p>\n<p>Initial claims for state unemployment benefits fell by 14,000 to 385,000 in the week ended July 31, while layoffs dropped to their lowest level in more than 21 years last month as companies held on to their workers amid a labor shortage, the Labor Department's report showed.</p>\n<p>\"The directional change has continued to be improving in the last few weeks and now it's a new low since beginning the pandemic,\" said Keith Buchanan, portfolio manager at Globalt Investments in Atlanta, Georgia. \"I think that's what (is) kind of leading to some optimism today and earnings to this point have been positive.\"</p>\n<p>Nine of the 11 major S&amp;P 500 sector indexes rose, with healthcare stocks in the red as Cigna Corp slipped 10.9% after predicting a bigger hit to full-year earnings from the pandemic.</p>\n<p>Focus will now shift to the jobs report for July on Friday. Analysts say a disappointing number might raise questions about an economic recovery, but it could also lead the Federal Reserve to remain accommodative.</p>\n<p>Meanwhile, Robinhood Markets Inc tumbled 27.6%, snapping a four-day rally fueled by interest from retail traders.</p>\n<p>ViacomCBS Inc jumped 7.1% as the company said it signed up the highest number of new streaming subscribers in the second quarter, and struck a multi-year deal with Comcast Corp's&nbsp;Sky to launch the Paramount+ streaming service in Europe.</p>\n<p>The Dow Jones Industrial Average rose 271.58 points, or 0.78%, to 35,064.25, the S&amp;P 500 gained 26.44 points, or 0.60%, to 4,429.1 and the Nasdaq Composite added 114.58 points, or 0.78%, to 14,895.12.</p>\n<p>Concerns about the pace of economic growth and higher inflation have pressured the S&amp;P 500 index, but stellar corporate earnings so far have put it on track to end the week higher.</p>\n<p>Fed Vice Chair Richard Clarida, a major architect of the central bank's new policy strategy, said on Wednesday he felt the conditions for raising interest rates could be met by the end of 2022.</p>\n<p>Volume on U.S. exchanges was 8.86 billion shares, compared with the 9.63 billion average for the full session over the last 20 trading days.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 2.06-to-1 ratio; on Nasdaq, a 2.26-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 52 new 52-week highs and 4 new lows; the Nasdaq Composite recorded 111 new highs and 103 new lows.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF博时","SPXU":"三倍做空标普500ETF-ProShares","SH":"做空标普500-Proshares","SPY":"标普500ETF","OEX":"标普100","SDS":"两倍做空标普500 ETF-ProShares","UPRO":"三倍做多标普500ETF-ProShares","CMCSA":"康卡斯特","CI":"信诺保险",".SPX":"S&P 500 Index","SSO":"2倍做多标普500ETF-ProShares","HOOD":"Robinhood","OEF":"标普100指数ETF-iShares",".DJI":"道琼斯","IVV":"标普500ETF-iShares",".IXIC":"NASDAQ Composite"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2157456017","content_text":"* Nasdaq, S&P 500 close at record highs\n* Layoff at lowest in over 21 years\n* Healthcare and materials sectoral losers on S&P 500\nAug 5 (Reuters) - The Nasdaq and S&P 500 closed at record levels on Thursday after a spate of strong corporate earnings and a further decline in U.S. unemployment claims last week, as investors weighed concerns of the surge of the Delta variant ahead of Friday's job's report.\nInitial claims for state unemployment benefits fell by 14,000 to 385,000 in the week ended July 31, while layoffs dropped to their lowest level in more than 21 years last month as companies held on to their workers amid a labor shortage, the Labor Department's report showed.\n\"The directional change has continued to be improving in the last few weeks and now it's a new low since beginning the pandemic,\" said Keith Buchanan, portfolio manager at Globalt Investments in Atlanta, Georgia. \"I think that's what (is) kind of leading to some optimism today and earnings to this point have been positive.\"\nNine of the 11 major S&P 500 sector indexes rose, with healthcare stocks in the red as Cigna Corp slipped 10.9% after predicting a bigger hit to full-year earnings from the pandemic.\nFocus will now shift to the jobs report for July on Friday. Analysts say a disappointing number might raise questions about an economic recovery, but it could also lead the Federal Reserve to remain accommodative.\nMeanwhile, Robinhood Markets Inc tumbled 27.6%, snapping a four-day rally fueled by interest from retail traders.\nViacomCBS Inc jumped 7.1% as the company said it signed up the highest number of new streaming subscribers in the second quarter, and struck a multi-year deal with Comcast Corp's Sky to launch the Paramount+ streaming service in Europe.\nThe Dow Jones Industrial Average rose 271.58 points, or 0.78%, to 35,064.25, the S&P 500 gained 26.44 points, or 0.60%, to 4,429.1 and the Nasdaq Composite added 114.58 points, or 0.78%, to 14,895.12.\nConcerns about the pace of economic growth and higher inflation have pressured the S&P 500 index, but stellar corporate earnings so far have put it on track to end the week higher.\nFed Vice Chair Richard Clarida, a major architect of the central bank's new policy strategy, said on Wednesday he felt the conditions for raising interest rates could be met by the end of 2022.\nVolume on U.S. exchanges was 8.86 billion shares, compared with the 9.63 billion average for the full session over the last 20 trading days.\nAdvancing issues outnumbered declining ones on the NYSE by a 2.06-to-1 ratio; on Nasdaq, a 2.26-to-1 ratio favored advancers.\nThe S&P 500 posted 52 new 52-week highs and 4 new lows; the Nasdaq Composite recorded 111 new highs and 103 new lows.","news_type":1,"symbols_score_info":{"161125":0.9,"513500":0.9,"HOOD":0.9,"OEF":0.9,"UPRO":0.9,"ESmain":0.9,"SPY":0.9,".DJI":0.9,"IVV":0.9,"SPXU":0.9,"CMCSA":0.9,".IXIC":0.9,"OEX":0.9,"SSO":0.9,"CI":0.9,"SDS":0.9,"VIAC":0.9,"SH":0.9,".SPX":0.9}},"isVote":1,"tweetType":1,"viewCount":469,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9006197088,"gmtCreate":1641629081547,"gmtModify":1676533636108,"author":{"id":"4087614954520500","authorId":"4087614954520500","name":"TANY0051","avatar":"https://static.tigerbbs.com/45437e79e37475d2911f2a4b2f84983d","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087614954520500","idStr":"4087614954520500"},"themes":[],"htmlText":"Great 👍&nbsp;","listText":"Great 👍&nbsp;","text":"Great 👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006197088","repostId":"1150907621","repostType":4,"repost":{"id":"1150907621","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1641607621,"share":"https://ttm.financial/m/news/1150907621?lang=en_US&edition=fundamental","pubTime":"2022-01-08 10:07","market":"us","language":"en","title":"Tesla Semis Could Be Delivered To PepsiCo In Late January","url":"https://stock-news.laohu8.com/highlight/detail?id=1150907621","media":"Benzinga","summary":"Electric vehicle giantTesla Incsurprised investors and customers in 2021 with an announcement that the highly anticipatedTesla Semiwould be delayed. A new report shows Semi deliveries could be just ar","content":"<html><head></head><body><p>Electric vehicle giant <b>Tesla Inc</b> surprised investors and customers in 2021 with an announcement that the highly anticipated <b>Tesla Semi</b> would be delayed. A new report shows Semi deliveries could be just around the corner.</p><p><img src=\"https://static.tigerbbs.com/9e0d630cfe6e37cabddb2883f1e52636\" tg-width=\"685\" tg-height=\"375\" width=\"100%\" height=\"auto\"/></p><p><b>What Happened:</b>A <b>Frito-Lay</b> facility in Modesto, California received Tesla Megachargers recently and is set to receive deliveries of Tesla Semis.</p><p>The <b>PepsiCo, Inc.</b> facility could receive Tesla Semis later this month, according to a report from Drive Tesla. Photos show Megachargers ready for installation and some in packaging. A Megapack battery storage system is also installed at the facility.</p><p><b>“After receiving these photos we were able to confirm with one of our sources that PepsiCo has been told to expect to receive all 15 Tesla Semis before the end of January,”</b>Drive Tesla said.</p><p>PepsiCo announced in a press release in March 2021 they would take delivery of 15 Tesla Semis before the end of 2021.</p><p>Tesla announced it was delaying the Tesla Semi during the second-quarter earnings release in 2021. Tesla CEO <b>Elon Musk</b> cited limited battery supply as one of the reasons for the Tesla Semi delay.</p><p>Despite the announced delays, PepsiCo CEO <b>Ramon Laguarta</b> shared in a CNBC interview in November 2021 that the company would be receiving Tesla Semis soon.</p><p>“We are getting our first deliveries this Q4,” Laguarta said.</p><p><b>Why It’s Important:</b>The comments from Laguarta suggested that Pepsi could have a different timeline than other companies or have preferred status from Tesla.</p><p>The purchase of Tesla Semis is one of several planned initiatives by PepsiCo to reduce its carbon emissions in the future, Laguarta added.</p><p>Pepsi is one of several large companies that have pledged to order Tesla Semis in the future. Pepsi placed an initial order for 100 Tesla Semis in 2017.</p><p>Tesla delayed the Tesla Semi into 2022 and new reports by the end of 2021 suggested Tesla Semis would not be delivered until 2023.</p><p><b>If reports hold true and PepsiCo receives its 15 Tesla Semis, it could lead to an improved timeline. But, it might be a one-off event possibly based on an exclusive deal or certain terms.</b></p><p>Tesla could see an increase in orders after its Tesla Semi is delivered. The event could also lead to public comments from PepsiCo that could lead to increased brand awareness of the semi-truck.</p><p>Investors and analysts eagerly await more updates on the Tesla Semi.</p><p><b>TSLA Price Action:</b>Tesla shares closed lower 3.54% at $1,026.96 on Friday.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla Semis Could Be Delivered To PepsiCo In Late January</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla Semis Could Be Delivered To PepsiCo In Late January\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2022-01-08 10:07</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Electric vehicle giant <b>Tesla Inc</b> surprised investors and customers in 2021 with an announcement that the highly anticipated <b>Tesla Semi</b> would be delayed. A new report shows Semi deliveries could be just around the corner.</p><p><img src=\"https://static.tigerbbs.com/9e0d630cfe6e37cabddb2883f1e52636\" tg-width=\"685\" tg-height=\"375\" width=\"100%\" height=\"auto\"/></p><p><b>What Happened:</b>A <b>Frito-Lay</b> facility in Modesto, California received Tesla Megachargers recently and is set to receive deliveries of Tesla Semis.</p><p>The <b>PepsiCo, Inc.</b> facility could receive Tesla Semis later this month, according to a report from Drive Tesla. Photos show Megachargers ready for installation and some in packaging. A Megapack battery storage system is also installed at the facility.</p><p><b>“After receiving these photos we were able to confirm with one of our sources that PepsiCo has been told to expect to receive all 15 Tesla Semis before the end of January,”</b>Drive Tesla said.</p><p>PepsiCo announced in a press release in March 2021 they would take delivery of 15 Tesla Semis before the end of 2021.</p><p>Tesla announced it was delaying the Tesla Semi during the second-quarter earnings release in 2021. Tesla CEO <b>Elon Musk</b> cited limited battery supply as one of the reasons for the Tesla Semi delay.</p><p>Despite the announced delays, PepsiCo CEO <b>Ramon Laguarta</b> shared in a CNBC interview in November 2021 that the company would be receiving Tesla Semis soon.</p><p>“We are getting our first deliveries this Q4,” Laguarta said.</p><p><b>Why It’s Important:</b>The comments from Laguarta suggested that Pepsi could have a different timeline than other companies or have preferred status from Tesla.</p><p>The purchase of Tesla Semis is one of several planned initiatives by PepsiCo to reduce its carbon emissions in the future, Laguarta added.</p><p>Pepsi is one of several large companies that have pledged to order Tesla Semis in the future. Pepsi placed an initial order for 100 Tesla Semis in 2017.</p><p>Tesla delayed the Tesla Semi into 2022 and new reports by the end of 2021 suggested Tesla Semis would not be delivered until 2023.</p><p><b>If reports hold true and PepsiCo receives its 15 Tesla Semis, it could lead to an improved timeline. But, it might be a one-off event possibly based on an exclusive deal or certain terms.</b></p><p>Tesla could see an increase in orders after its Tesla Semi is delivered. The event could also lead to public comments from PepsiCo that could lead to increased brand awareness of the semi-truck.</p><p>Investors and analysts eagerly await more updates on the Tesla Semi.</p><p><b>TSLA Price Action:</b>Tesla shares closed lower 3.54% at $1,026.96 on Friday.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1150907621","content_text":"Electric vehicle giant Tesla Inc surprised investors and customers in 2021 with an announcement that the highly anticipated Tesla Semi would be delayed. A new report shows Semi deliveries could be just around the corner.What Happened:A Frito-Lay facility in Modesto, California received Tesla Megachargers recently and is set to receive deliveries of Tesla Semis.The PepsiCo, Inc. facility could receive Tesla Semis later this month, according to a report from Drive Tesla. Photos show Megachargers ready for installation and some in packaging. A Megapack battery storage system is also installed at the facility.“After receiving these photos we were able to confirm with one of our sources that PepsiCo has been told to expect to receive all 15 Tesla Semis before the end of January,”Drive Tesla said.PepsiCo announced in a press release in March 2021 they would take delivery of 15 Tesla Semis before the end of 2021.Tesla announced it was delaying the Tesla Semi during the second-quarter earnings release in 2021. Tesla CEO Elon Musk cited limited battery supply as one of the reasons for the Tesla Semi delay.Despite the announced delays, PepsiCo CEO Ramon Laguarta shared in a CNBC interview in November 2021 that the company would be receiving Tesla Semis soon.“We are getting our first deliveries this Q4,” Laguarta said.Why It’s Important:The comments from Laguarta suggested that Pepsi could have a different timeline than other companies or have preferred status from Tesla.The purchase of Tesla Semis is one of several planned initiatives by PepsiCo to reduce its carbon emissions in the future, Laguarta added.Pepsi is one of several large companies that have pledged to order Tesla Semis in the future. Pepsi placed an initial order for 100 Tesla Semis in 2017.Tesla delayed the Tesla Semi into 2022 and new reports by the end of 2021 suggested Tesla Semis would not be delivered until 2023.If reports hold true and PepsiCo receives its 15 Tesla Semis, it could lead to an improved timeline. But, it might be a one-off event possibly based on an exclusive deal or certain terms.Tesla could see an increase in orders after its Tesla Semi is delivered. The event could also lead to public comments from PepsiCo that could lead to increased brand awareness of the semi-truck.Investors and analysts eagerly await more updates on the Tesla Semi.TSLA Price Action:Tesla shares closed lower 3.54% at $1,026.96 on Friday.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":4250,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":818763729,"gmtCreate":1630450761361,"gmtModify":1676530304123,"author":{"id":"4087614954520500","authorId":"4087614954520500","name":"TANY0051","avatar":"https://static.tigerbbs.com/45437e79e37475d2911f2a4b2f84983d","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087614954520500","idStr":"4087614954520500"},"themes":[],"htmlText":"Go go go","listText":"Go go go","text":"Go go go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/818763729","repostId":"1165958269","repostType":4,"repost":{"id":"1165958269","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1630418022,"share":"https://ttm.financial/m/news/1165958269?lang=en_US&edition=fundamental","pubTime":"2021-08-31 21:53","market":"us","language":"en","title":"Moderna shares rose more than 2% in early trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1165958269","media":"Tiger Newspress","summary":"Moderna shares rose more than 2% in early trading.\n\n\nA study examining the immune response of Modern","content":"<p>Moderna&nbsp;shares&nbsp;rose&nbsp;more&nbsp;than&nbsp;2%&nbsp;in&nbsp;early&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/e3a6617d6ec5a20d69a181840ef582fb\" tg-width=\"885\" tg-height=\"634\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li>A study examining the immune response of Moderna's&nbsp;COVID-19 vaccine to Pfizer&nbsp;/BioNTech's&nbsp;found that the former created more than twice as many antibodies as the latter.</li>\n <li>The study, published in the<i>Journal of the American Medical Association</i>, examined 2,499 health care workers in Belgium inoculated with one of the two vaccines.</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna shares rose more than 2% in early trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna shares rose more than 2% in early trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-31 21:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Moderna&nbsp;shares&nbsp;rose&nbsp;more&nbsp;than&nbsp;2%&nbsp;in&nbsp;early&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/e3a6617d6ec5a20d69a181840ef582fb\" tg-width=\"885\" tg-height=\"634\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li>A study examining the immune response of Moderna's&nbsp;COVID-19 vaccine to Pfizer&nbsp;/BioNTech's&nbsp;found that the former created more than twice as many antibodies as the latter.</li>\n <li>The study, published in the<i>Journal of the American Medical Association</i>, examined 2,499 health care workers in Belgium inoculated with one of the two vaccines.</li>\n</ul>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","MRNA":"Moderna, Inc.","PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1165958269","content_text":"Moderna shares rose more than 2% in early trading.\n\n\nA study examining the immune response of Moderna's COVID-19 vaccine to Pfizer /BioNTech's found that the former created more than twice as many antibodies as the latter.\nThe study, published in theJournal of the American Medical Association, examined 2,499 health care workers in Belgium inoculated with one of the two vaccines.","news_type":1,"symbols_score_info":{"BNTX":0.9,"MRNA":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":4015,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":837542027,"gmtCreate":1629901914469,"gmtModify":1676530167819,"author":{"id":"4087614954520500","authorId":"4087614954520500","name":"TANY0051","avatar":"https://static.tigerbbs.com/45437e79e37475d2911f2a4b2f84983d","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087614954520500","idStr":"4087614954520500"},"themes":[],"htmlText":"Way to go","listText":"Way to go","text":"Way to go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/837542027","repostId":"2162051949","repostType":4,"repost":{"id":"2162051949","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1629899991,"share":"https://ttm.financial/m/news/2162051949?lang=en_US&edition=fundamental","pubTime":"2021-08-25 21:59","market":"us","language":"en","title":"Moderna shares surged 4% in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2162051949","media":"Tiger Newspress","summary":"Moderna shares surged 4% in morning trading on completing submission of BLA to U.S. Food and Drug Ad","content":"<p>Moderna shares surged 4% in morning trading&nbsp;on&nbsp;completing submission of BLA to U.S. Food and Drug Administration for its COVID-19 Vaccine.</p>\n<p><img src=\"https://static.tigerbbs.com/333b7cf1e02c99fd0d5925c7c1931da0\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>\n<p><a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a> (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced it has completed the rolling submission process for its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the full licensure of the Moderna COVID-19 Vaccine for active immunization to prevent COVID-19 in individuals 18 years of age and older. As part of the completed BLA submission, Moderna has requested Priority Review designation.</p>\n<p>“This BLA submission for our COVID-19 vaccine, which we began in June, is an important milestone in our battle against COVID-19 and for Moderna, as this is the first BLA submission in our company’s history,” said Stéphane Bancel, Chief Executive Officer of Moderna. “We are pleased that our COVID-19 vaccine is showing durable efficacy of 93% through six months after dose 2. I want to thank the people who participated in our clinical studies, as well as the staff at clinical trial sites who have been on the front lines of the fight against the virus. I would again like to thank our partners at NIH, NIAID and BARDA who have helped us advance the clinical development of our mRNA COVID-19 vaccine. I would also like to thank the U.S. FDA for their hard work and guidance through the BLA submission process and the entire Moderna team for their relentlessness in pursuing our mission of delivering on the promise of mRNA science.”</p>\n<p>The FDA Fast Track designation received on May 12, 2020 has permitted Moderna to submit sections of the BLA on a rolling basis and Moderna announced the initiation of the BLA submission on June 1, 2021. The completed submission includes clinical data from the Phase 3 COVE study of the Moderna COVID-19 vaccine, which enrolled more than 30,000 participants in the U.S. and was conducted in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), and the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services. In final analysis of Phase 3 COVE study data, the Moderna COVID-19 vaccine showed 93% efficacy, with the efficacy remaining durable through six months after administration of the second dose. In the COVE study, reported adverse reactions included pain at the injection site, fatigue, headache, myalgia, arthralgia, chills, nausea/vomiting, axillary swelling/tenderness, fever, swelling at the injection site, and erythema at the injection site.</p>\n<p>The Moderna COVID-19 vaccine is currently available in the U.S. for individuals 18 years of age and older under an Emergency Use Authorization (EUA) granted by the FDA on December 18, 2020. Since then, Moderna has released more than 300 million doses of the vaccine to the U.S. government.</p>\n<p>Moderna has also filed for an Emergency Use Authorization (EUA) for adolescents ages 12 and above with the U.S. FDA.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna shares surged 4% in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna shares surged 4% in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-25 21:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Moderna shares surged 4% in morning trading&nbsp;on&nbsp;completing submission of BLA to U.S. Food and Drug Administration for its COVID-19 Vaccine.</p>\n<p><img src=\"https://static.tigerbbs.com/333b7cf1e02c99fd0d5925c7c1931da0\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>\n<p><a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a> (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced it has completed the rolling submission process for its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the full licensure of the Moderna COVID-19 Vaccine for active immunization to prevent COVID-19 in individuals 18 years of age and older. As part of the completed BLA submission, Moderna has requested Priority Review designation.</p>\n<p>“This BLA submission for our COVID-19 vaccine, which we began in June, is an important milestone in our battle against COVID-19 and for Moderna, as this is the first BLA submission in our company’s history,” said Stéphane Bancel, Chief Executive Officer of Moderna. “We are pleased that our COVID-19 vaccine is showing durable efficacy of 93% through six months after dose 2. I want to thank the people who participated in our clinical studies, as well as the staff at clinical trial sites who have been on the front lines of the fight against the virus. I would again like to thank our partners at NIH, NIAID and BARDA who have helped us advance the clinical development of our mRNA COVID-19 vaccine. I would also like to thank the U.S. FDA for their hard work and guidance through the BLA submission process and the entire Moderna team for their relentlessness in pursuing our mission of delivering on the promise of mRNA science.”</p>\n<p>The FDA Fast Track designation received on May 12, 2020 has permitted Moderna to submit sections of the BLA on a rolling basis and Moderna announced the initiation of the BLA submission on June 1, 2021. The completed submission includes clinical data from the Phase 3 COVE study of the Moderna COVID-19 vaccine, which enrolled more than 30,000 participants in the U.S. and was conducted in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), and the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services. In final analysis of Phase 3 COVE study data, the Moderna COVID-19 vaccine showed 93% efficacy, with the efficacy remaining durable through six months after administration of the second dose. In the COVE study, reported adverse reactions included pain at the injection site, fatigue, headache, myalgia, arthralgia, chills, nausea/vomiting, axillary swelling/tenderness, fever, swelling at the injection site, and erythema at the injection site.</p>\n<p>The Moderna COVID-19 vaccine is currently available in the U.S. for individuals 18 years of age and older under an Emergency Use Authorization (EUA) granted by the FDA on December 18, 2020. Since then, Moderna has released more than 300 million doses of the vaccine to the U.S. government.</p>\n<p>Moderna has also filed for an Emergency Use Authorization (EUA) for adolescents ages 12 and above with the U.S. FDA.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2162051949","content_text":"Moderna shares surged 4% in morning trading on completing submission of BLA to U.S. Food and Drug Administration for its COVID-19 Vaccine.\n\nModerna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced it has completed the rolling submission process for its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the full licensure of the Moderna COVID-19 Vaccine for active immunization to prevent COVID-19 in individuals 18 years of age and older. As part of the completed BLA submission, Moderna has requested Priority Review designation.\n“This BLA submission for our COVID-19 vaccine, which we began in June, is an important milestone in our battle against COVID-19 and for Moderna, as this is the first BLA submission in our company’s history,” said Stéphane Bancel, Chief Executive Officer of Moderna. “We are pleased that our COVID-19 vaccine is showing durable efficacy of 93% through six months after dose 2. I want to thank the people who participated in our clinical studies, as well as the staff at clinical trial sites who have been on the front lines of the fight against the virus. I would again like to thank our partners at NIH, NIAID and BARDA who have helped us advance the clinical development of our mRNA COVID-19 vaccine. I would also like to thank the U.S. FDA for their hard work and guidance through the BLA submission process and the entire Moderna team for their relentlessness in pursuing our mission of delivering on the promise of mRNA science.”\nThe FDA Fast Track designation received on May 12, 2020 has permitted Moderna to submit sections of the BLA on a rolling basis and Moderna announced the initiation of the BLA submission on June 1, 2021. The completed submission includes clinical data from the Phase 3 COVE study of the Moderna COVID-19 vaccine, which enrolled more than 30,000 participants in the U.S. and was conducted in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), and the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services. In final analysis of Phase 3 COVE study data, the Moderna COVID-19 vaccine showed 93% efficacy, with the efficacy remaining durable through six months after administration of the second dose. In the COVE study, reported adverse reactions included pain at the injection site, fatigue, headache, myalgia, arthralgia, chills, nausea/vomiting, axillary swelling/tenderness, fever, swelling at the injection site, and erythema at the injection site.\nThe Moderna COVID-19 vaccine is currently available in the U.S. for individuals 18 years of age and older under an Emergency Use Authorization (EUA) granted by the FDA on December 18, 2020. Since then, Moderna has released more than 300 million doses of the vaccine to the U.S. government.\nModerna has also filed for an Emergency Use Authorization (EUA) for adolescents ages 12 and above with the U.S. FDA.","news_type":1,"symbols_score_info":{"MRNA":0.9}},"isVote":1,"tweetType":1,"viewCount":869,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":274441423143176,"gmtCreate":1708040095129,"gmtModify":1708040097687,"author":{"id":"4087614954520500","authorId":"4087614954520500","name":"TANY0051","avatar":"https://static.tigerbbs.com/45437e79e37475d2911f2a4b2f84983d","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087614954520500","idStr":"4087614954520500"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$&nbsp;</a> Continue to grow","listText":"<a href=\"https://ttm.financial/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$&nbsp;</a> Continue to grow","text":"$SINGAPORE AIRLINES LTD(C6L.SI)$ Continue to grow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/274441423143176","isVote":1,"tweetType":1,"viewCount":2423,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":897039454,"gmtCreate":1628862213778,"gmtModify":1676529878364,"author":{"id":"4087614954520500","authorId":"4087614954520500","name":"TANY0051","avatar":"https://static.tigerbbs.com/45437e79e37475d2911f2a4b2f84983d","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087614954520500","idStr":"4087614954520500"},"themes":[],"htmlText":"[Smile]&nbsp;","listText":"[Smile]&nbsp;","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/897039454","repostId":"1141206470","repostType":4,"repost":{"id":"1141206470","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628861824,"share":"https://ttm.financial/m/news/1141206470?lang=en_US&edition=fundamental","pubTime":"2021-08-13 21:37","market":"us","language":"en","title":"BioNTech, Moderna Rise On Nod To Booster For Those With Weak Immunity","url":"https://stock-news.laohu8.com/highlight/detail?id=1141206470","media":"Tiger Newspress","summary":"BioNTech and Moderna stocks were up in early trading following the FDA authorizing Covid-19 booster ","content":"<p>BioNTech&nbsp;and Moderna&nbsp;stocks were up in&nbsp;early&nbsp;trading following the FDA authorizing Covid-19 booster shots for people with weak immunity.</p>\n<p>BioNTech was up 3% and Moderna gained 3%, while Pfizer&nbsp;, which has jointly developed the two-dose mRNA vaccine with BioNTech, was up 2%.</p>\n<p><img src=\"https://static.tigerbbs.com/18d1d9877f2ba36a61eaf23f41b8914f\" tg-width=\"898\" tg-height=\"607\" referrerpolicy=\"no-referrer\"></p>\n<p>Late on Thursday, the U.S. Food and Drug Administration&nbsp;authorized a booster doseof vaccines from Pfizer Inc(PFE.N)and Moderna Inc(MRNA.O)for people with compromised immune systems.</p>\n<p>Pfizer, along with its German partner BioNTech , and Moderna have together locked up over $60 billion in sales of the shots just in 2021 and 2022. The agreements include supply of the initial two doses of their vaccines as well as billions of dollars in potential boosters for wealthy nations.</p>\n<p>Going forward, analysts have forecast revenue of over $6.6 billion for the Pfizer/BioNTech shot and $7.6 billion for Moderna in 2023, mostly from booster sales. They eventually see the annual market settling at around $5 billion or higher, with additional drugmakers competing for those sales.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioNTech, Moderna Rise On Nod To Booster For Those With Weak Immunity</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioNTech, Moderna Rise On Nod To Booster For Those With Weak Immunity\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-13 21:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BioNTech&nbsp;and Moderna&nbsp;stocks were up in&nbsp;early&nbsp;trading following the FDA authorizing Covid-19 booster shots for people with weak immunity.</p>\n<p>BioNTech was up 3% and Moderna gained 3%, while Pfizer&nbsp;, which has jointly developed the two-dose mRNA vaccine with BioNTech, was up 2%.</p>\n<p><img src=\"https://static.tigerbbs.com/18d1d9877f2ba36a61eaf23f41b8914f\" tg-width=\"898\" tg-height=\"607\" referrerpolicy=\"no-referrer\"></p>\n<p>Late on Thursday, the U.S. Food and Drug Administration&nbsp;authorized a booster doseof vaccines from Pfizer Inc(PFE.N)and Moderna Inc(MRNA.O)for people with compromised immune systems.</p>\n<p>Pfizer, along with its German partner BioNTech , and Moderna have together locked up over $60 billion in sales of the shots just in 2021 and 2022. The agreements include supply of the initial two doses of their vaccines as well as billions of dollars in potential boosters for wealthy nations.</p>\n<p>Going forward, analysts have forecast revenue of over $6.6 billion for the Pfizer/BioNTech shot and $7.6 billion for Moderna in 2023, mostly from booster sales. They eventually see the annual market settling at around $5 billion or higher, with additional drugmakers competing for those sales.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","PFE":"辉瑞","MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1141206470","content_text":"BioNTech and Moderna stocks were up in early trading following the FDA authorizing Covid-19 booster shots for people with weak immunity.\nBioNTech was up 3% and Moderna gained 3%, while Pfizer , which has jointly developed the two-dose mRNA vaccine with BioNTech, was up 2%.\n\nLate on Thursday, the U.S. Food and Drug Administration authorized a booster doseof vaccines from Pfizer Inc(PFE.N)and Moderna Inc(MRNA.O)for people with compromised immune systems.\nPfizer, along with its German partner BioNTech , and Moderna have together locked up over $60 billion in sales of the shots just in 2021 and 2022. The agreements include supply of the initial two doses of their vaccines as well as billions of dollars in potential boosters for wealthy nations.\nGoing forward, analysts have forecast revenue of over $6.6 billion for the Pfizer/BioNTech shot and $7.6 billion for Moderna in 2023, mostly from booster sales. They eventually see the annual market settling at around $5 billion or higher, with additional drugmakers competing for those sales.","news_type":1,"symbols_score_info":{"PFE":0.9,"BNTX":0.9,"MRNA":0.9}},"isVote":1,"tweetType":1,"viewCount":1312,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":898507538,"gmtCreate":1628507266724,"gmtModify":1703507241820,"author":{"id":"4087614954520500","authorId":"4087614954520500","name":"TANY0051","avatar":"https://static.tigerbbs.com/45437e79e37475d2911f2a4b2f84983d","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087614954520500","idStr":"4087614954520500"},"themes":[],"htmlText":"[Sad]&nbsp;","listText":"[Sad]&nbsp;","text":"[Sad]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/898507538","repostId":"1112407855","repostType":4,"repost":{"id":"1112407855","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628496113,"share":"https://ttm.financial/m/news/1112407855?lang=en_US&edition=fundamental","pubTime":"2021-08-09 16:01","market":"us","language":"en","title":"Alibaba shares fell 1.57% in premarket trading.","url":"https://stock-news.laohu8.com/highlight/detail?id=1112407855","media":"Tiger Newspress","summary":"Alibaba shares fell 1.57% in premarket trading.\nChinese technology giant Alibaba will sack a manager","content":"<p>Alibaba&nbsp;shares fell 1.57% in premarket&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/df9ce7af138f3ccf40c454cdf5b6a716\" tg-width=\"1285\" tg-height=\"614\" referrerpolicy=\"no-referrer\">Chinese technology giant Alibaba will sack a manager accused of rape, according to a memo seen by the BBC.</p>\n<p>In the letter sent to employees of the firm, chief executive Daniel Zhang said two other bosses who failed to act on the allegation have resigned.</p>\n<p>Alibaba is working with police after a female worker said her male boss raped her in a hotel room while she was unconscious after a \"drunken night\".</p>\n<p>Her allegations have been widely shared on Chinese social media.</p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alibaba shares fell 1.57% in premarket trading.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlibaba shares fell 1.57% in premarket trading.\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-09 16:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Alibaba&nbsp;shares fell 1.57% in premarket&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/df9ce7af138f3ccf40c454cdf5b6a716\" tg-width=\"1285\" tg-height=\"614\" referrerpolicy=\"no-referrer\">Chinese technology giant Alibaba will sack a manager accused of rape, according to a memo seen by the BBC.</p>\n<p>In the letter sent to employees of the firm, chief executive Daniel Zhang said two other bosses who failed to act on the allegation have resigned.</p>\n<p>Alibaba is working with police after a female worker said her male boss raped her in a hotel room while she was unconscious after a \"drunken night\".</p>\n<p>Her allegations have been widely shared on Chinese social media.</p>\n<p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BABA":"阿里巴巴"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1112407855","content_text":"Alibaba shares fell 1.57% in premarket trading.\nChinese technology giant Alibaba will sack a manager accused of rape, according to a memo seen by the BBC.\nIn the letter sent to employees of the firm, chief executive Daniel Zhang said two other bosses who failed to act on the allegation have resigned.\nAlibaba is working with police after a female worker said her male boss raped her in a hotel room while she was unconscious after a \"drunken night\".\nHer allegations have been widely shared on Chinese social media.","news_type":1,"symbols_score_info":{"BABA":0.9}},"isVote":1,"tweetType":1,"viewCount":653,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":812091480,"gmtCreate":1630540235140,"gmtModify":1676530332318,"author":{"id":"4087614954520500","authorId":"4087614954520500","name":"TANY0051","avatar":"https://static.tigerbbs.com/45437e79e37475d2911f2a4b2f84983d","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087614954520500","idStr":"4087614954520500"},"themes":[],"htmlText":"Way to go","listText":"Way to go","text":"Way to go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/812091480","repostId":"2164481914","repostType":4,"isVote":1,"tweetType":1,"viewCount":3034,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":810525704,"gmtCreate":1629987604508,"gmtModify":1676530194163,"author":{"id":"4087614954520500","authorId":"4087614954520500","name":"TANY0051","avatar":"https://static.tigerbbs.com/45437e79e37475d2911f2a4b2f84983d","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087614954520500","idStr":"4087614954520500"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/INO\">$Inovio Pharmaceuticals(INO)$</a>Go go go","listText":"<a href=\"https://laohu8.com/S/INO\">$Inovio Pharmaceuticals(INO)$</a>Go go go","text":"$Inovio Pharmaceuticals(INO)$Go go go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/810525704","isVote":1,"tweetType":1,"viewCount":843,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}